Document:

Exhibit 4.4

 

PASSAGE BIO, INC.

 

And

 

             , as Trustee

 

INDENTURE

 

Dated as of                 ,

 

     

     

    

 

TABLE OF CONTENTS

 

	ARTICLE 1 – DEFINITIONS AND INCORPORATION BY REFERENCE	 	1	 
	1.1 DEFINITIONS	 	1	 
	1.2. OTHER DEFINITIONS	 	4	 
	1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT	 	4	 
	1.4. RULES OF CONSTRUCTION	 	5	 
	ARTICLE 2 – THE SECURITIES	 	5	 
	2.1. ISSUABLE IN SERIES	 	5	 
	2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES	 	5	 
	2.3. EXECUTION AND AUTHENTICATION	 	8	 
	2.4. REGISTRAR AND PAYING AGENT	 	8	 
	2.5. PAYING AGENT TO HOLD ASSETS IN TRUST	 	9	 
	2.6. SECURITYHOLDER LISTS	 	9	 
	2.7. TRANSFER AND EXCHANGE	 	9	 
	2.8. REPLACEMENT SECURITIES	 	10	 
	2.9. OUTSTANDING SECURITIES	 	10	 
	2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION	 	10	 
	2.11. TEMPORARY SECURITIES	 	10	 
	2.12. CANCELLATION	 	11	 
	2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST	 	11	 
	2.14. CUSIP NUMBER	 	11	 
	2.15. PROVISIONS FOR GLOBAL SECURITIES	 	12	 
	2.16. PERSONS DEEMED OWNERS	 	12	 
	ARTICLE 3 – REDEMPTION	 	13	 
	3.1. NOTICES TO TRUSTEE	 	13	 
	3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED	 	13	 
	3.3. NOTICE OF REDEMPTION	 	13	 
	3.4. EFFECT OF NOTICE OF REDEMPTION	 	14	 
	3.5. DEPOSIT OF REDEMPTION PRICE	 	14	 
	3.6. SECURITIES REDEEMED IN PART	 	14	 
	ARTICLE 4 – COVENANTS	 	15	 
	4.1. PAYMENT OF SECURITIES	 	15	 
	4.2. SEC REPORTS	 	15	 
	4.3. WAIVER OF STAY, EXTENSION OR USURY LAWS	 	15	 
	4.4. COMPLIANCE CERTIFICATE	 	15	 
	4.5. CORPORATE EXISTENCE	 	15	 
	ARTICLE 5 – SUCCESSOR CORPORATION	 	16	 
	5.1. LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS	 	16	 
	5.2. SUCCESSOR PERSON SUBSTITUTED	 	16	 
	ARTICLE 6 – DEFAULTS AND REMEDIES	 	17	 
	6.1. EVENTS OF DEFAULT	 	17	 
	6.2. ACCELERATION	 	18	 
	6.3. REMEDIES	 	18	 
	6.4. WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT	 	18	 
	6.5. CONTROL BY MAJORITY	 	19	 
	6.6. LIMITATION ON SUITS	 	19	 
	6.7. RIGHTS OF HOLDERS TO RECEIVE PAYMENT	 	19	 
	6.8. COLLECTION SUIT BY TRUSTEE	 	20	 
	6.9. TRUSTEE MAY FILE PROOFS OF CLAIM	 	20	 
	6.10. PRIORITIES	 	20	 
	6.11. UNDERTAKING FOR COSTS	 	21	 
	ARTICLE 7 – TRUSTEE	 	21	 
	7.1. DUTIES OF TRUSTEE	 	21	 
	7.2. RIGHTS OF TRUSTEE	 	22	 
	7.3. INDIVIDUAL RIGHTS OF TRUSTEE	 	22	 
	7.4. TRUSTEE’S DISCLAIMER	 	22	 
	7.5. NOTICE OF DEFAULT	 	22	 
	7.6. REPORTS BY TRUSTEE TO HOLDERS	 	23	 
	7.7. COMPENSATION AND INDEMNITY	 	23	 

 

    i

     

    

 

	7.8. REPLACEMENT OF TRUSTEE	 	23	 
	7.9. SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION	 	24	 
	7.10. ELIGIBILITY; DISQUALIFICATION	 	24	 
	7.11. PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY	 	24	 
	7.12. PAYING AGENTS	 	24	 
	ARTICLE 8 – AMENDMENTS, SUPPLEMENTS AND WAIVERS	 	24	 
	8.1. WITHOUT CONSENT OF HOLDERS	 	24	 
	8.2. WITH CONSENT OF HOLDERS	 	25	 
	8.3. COMPLIANCE WITH TRUST INDENTURE ACT	 	25	 
	8.4. REVOCATION AND EFFECT OF CONSENTS	 	26	 
	8.5. NOTATION ON OR EXCHANGE OF SECURITIES	 	26	 
	8.6. TRUSTEE TO SIGN AMENDMENTS, ETC.	 	26	 
	ARTICLE 9 – DISCHARGE OF INDENTURE; DEFEASANCE	 	26	 
	9.1. DISCHARGE OF INDENTURE	 	26	 
	9.2. LEGAL DEFEASANCE	 	27	 
	9.3. COVENANT DEFEASANCE	 	27	 
	9.4. CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE	 	27	 
	9.5. DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER MISCELLANEOUS PROVISIONS	 	28	 
	9.6. REINSTATEMENT	 	28	 
	9.7. MONEYS HELD BY PAYING AGENT	 	28	 
	9.8. MONEYS HELD BY TRUSTEE	 	29	 
	ARTICLE 10 – MISCELLANEOUS	 	29	 
	10.1. TRUST INDENTURE ACT CONTROLS	 	29	 
	10.2. NOTICES	 	29	 
	10.3. COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS	 	30	 
	10.4. CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT	 	30	 
	10.5. STATEMENT REQUIRED IN CERTIFICATE AND OPINION	 	30	 
	10.6. RULES BY TRUSTEE AND AGENTS	 	30	 
	10.7. BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT	 	30	 
	10.8. GOVERNING LAW	 	30	 
	10.9. NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS	 	30	 
	10.10. NO RECOURSE AGAINST OTHERS	 	31	 
	10.11. SUCCESSORS	 	31	 
	10.12. MULTIPLE COUNTERPARTS	 	31	 
	10.13. TABLE OF CONTENTS, HEADINGS, ETC.	 	31	 
	10.14. SEVERABILITY	 	31	 
	10.15. SECURITIES IN A FOREIGN CURRENCY OR IN EUROS	 	31	 
	10.16. JUDGMENT CURRENCY	 	32	 

 

    ii

     

    

 

INDENTURE, dated as of                 ,
                 , by and between Passage Bio, Inc.,
a Delaware corporation, as Issuer (the “Company”) and                 ,
a                  organized under the laws of
                         ,
as Trustee (the “Trustee”).

 

RECITALS OF THE COMPANY

 

The Company has duly authorized the execution
and delivery of this Indenture to provide for the issuance from time to time of its debentures, notes or other evidences of indebtedness
to be issued in one or more series (the “Securities”), as herein provided, up to such principal amount as may from
time to time be authorized in or pursuant to one or more resolutions of the Board of Directors or by supplemental indenture.

 

All things necessary to make this Indenture
a valid agreement of the Company in accordance with its terms have been done, and the execution and delivery thereof have been
in all respects duly authorized by the parties hereto.

 

NOW, THEREFORE, THIS INDENTURE WITNESSETH:

 

For and in consideration of the premises
and the purchase of the Securities by the Holders thereof, it is mutually agreed, for the equal and proportionate benefit of all
Holders of the Securities of a Series thereof, as follows:

 

ARTICLE 1 –

DEFINITIONS AND INCORPORATION BY REFERENCE

 

1.1 DEFINITIONS.

 

“Affiliate” of any specified
Person means any other Person which, directly or indirectly through one or more intermediaries, controls, or is controlled by or
is under common control with, such specified Person. For the purposes of this definition, “control” (including, with
correlative meanings, the terms “controlling,” “controlled by” and “under common control with”),
as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction
of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise.

 

“Agent” means any Registrar,
Paying Agent, co-registrar or agent for service of notices and demands.

 

“Board of Directors” means
the Board of Directors of the Company or any committee duly authorized to act therefor.

 

“Board Resolution” means a
copy of a resolution certified pursuant to an Officers’ Certificate to have been duly adopted by the Board of Directors of
the Company and to be in full force and effect on the date of such certification which has been delivered to the Trustee.

 

“Capital Stock” means, with
respect to any Person, any and all shares or other equivalents (however designated) of capital stock, partnership interests or
any other participation, right or other interest in the nature of an equity interest in such Person or any option, warrant or other
security convertible into any of the foregoing.

 

“Company” means the party named
as such in the first paragraph of this Indenture until a successor replaces such party pursuant to Article 5 of this Indenture,
and thereafter means the successor and any other primary obligor on the Securities.

 

“Company Order” means a written
order signed in the name of the Company by two Officers, one of whom must be its Chief Executive Officer or its Chief Financial
Officer.

 

“Company Request” means any
written request signed in the name of the Company by its Chief Executive Officer, its President, any Vice President, its Chief
Financial Officer or its Treasurer and attested to by its Secretary or any Assistant Secretary.

 

“Corporate Trust Office” means
the office of the Trustee at which at any particular time its corporate trust business shall be principally administered.

 

“Default” means any event that
is, or that with the passing of time or giving of notice or both would be, an Event of Default.

 

    1

     

    

 

“Depository” means, with
respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global
Securities, the Person designated as Depository for such Series by the Company, which Depository shall be a clearing
agency registered under the Exchange Act, until a successor Depository shall have become such pursuant to the applicable
provisions of this Indenture, and thereafter “Depository” shall mean each Person who is then a Depository
hereunder, and if at any time there is more than one such Person, such Persons.

 

“Dollars” means the currency
of the United States of America.

 

“Euro” means the single currency
of participating member states of the economic and monetary union as contemplated in the Treaty on European Union.

 

“Exchange Act” means the Securities
Exchange Act of 1934, as amended.

 

“Foreign Currency” means any
currency or currency unit issued by a government other than the government of the United States of America.

 

“Foreign Government Obligations”
means, with respect to Securities that are denominated in a Foreign Currency, (i) direct obligations of the government that
issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged or (ii) obligations
of a Person controlled or supervised by, or acting as an agency or instrumentality of, such government, the timely payment of which
is unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i) and
(ii), are not callable or redeemable at the option of the issuer thereof.

 

“GAAP” means generally accepted
accounting principles consistently applied as in effect in the United States of America from time to time.

 

“Global Security” or “Global
Securities” means a Security or Securities, as the case may be, in the form established pursuant to Section 2.2, evidencing
all or part of a Series of Securities issued to the Depository for such Series or its nominee, and registered in the
name of such Depository or nominee, and bearing the legend set forth in Section 2.15(c) (or such other legend(s) as
may be applied to such Securities in accordance with Section 2.2(24)).

 

“Holder” or “Securityholder”
means the Person in whose name a Security is registered on the Registrar’s books.

 

“Indebtedness” means (without
duplication), with respect to any Person, any indebtedness at any time outstanding, secured or unsecured, contingent or otherwise,
which is for borrowed money (whether or not the recourse of the lender is to the whole of the assets of such Person or only to
a portion thereof), or evidenced by bonds, notes, debentures or similar instruments, or representing the balance, deferred and
unpaid, of the purchase price of any property (excluding any balances that constitute accounts payable or trade payables, and other
accrued liabilities arising in the ordinary course of business), if and to the extent any of the foregoing indebtedness would appear
as a liability upon a balance sheet of such Person prepared in accordance with GAAP.

 

“Indenture” means this Indenture
as amended, restated or supplemented from time to time.

 

“Interest Payment Date,” when
used with respect to any Security, means the Stated Maturity of an installment of interest on such Security.

 

“Lien” means, with respect
to any property or assets of any Person, any mortgage or deed of trust, pledge, hypothecation, assignment, deposit arrangement,
security interest, lien, charge, easement, encumbrance, preference, priority or other security agreement or preferential arrangement
of any kind or nature whatsoever on or with respect to such property or assets (including, without limitation, any capitalized
lease obligation, conditional sales or other title retention agreement having substantially the same economic effect as any of
the foregoing).

 

“Maturity,” when used with
respect to any Security, means the date on which the principal of such Security, or an installment of principal, becomes due and
payable as therein or herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption, notice
of option to elect payment or otherwise.

 

“Officer” means the Chief Executive
Officer, the President, any Vice President, the Chief Financial Officer, the Treasurer or the Secretary of the Company, or any
other officer designated by the Board of Directors, as the case may be.

 

“Officers’ Certificate”
means, with respect to any Person, a certificate signed by the Chairman, Chief Executive Officer, President, any Vice President
or Secretary and the Chief Financial Officer or any Treasurer of such Person, that shall comply with applicable provisions of this
Indenture.

 

    2

     

    

 

“Opinion of Counsel” means
a written opinion from legal counsel, which counsel is reasonably acceptable to the Trustee. The counsel may be an employee of
or outside counsel to the Company.

 

“Person” means any individual,
corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, unincorporated organization
or government (including any agency or political subdivision thereof).

 

“Redemption Date,” when used
with respect to any Security to be redeemed, means the date fixed for such redemption pursuant to this Indenture.

 

“Responsible Officer,” when
used with respect to the Trustee, means any officer within the corporate trust department or division of the Trustee (or any successor
group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of
the above designated officers, and also means, with respect to a particular corporate trust matter, any other officer to whom such
matter is referred because of his knowledge of and familiarity with the particular subject.

 

“SEC” means the United States
Securities and Exchange Commission as constituted from time to time, or any successor performing substantially the same functions.

 

“Securities” means the securities
that are issued under this Indenture, as amended, restated or supplemented from time to time pursuant to this Indenture.

 

“Securities Act” means the
Securities Act of 1933, as amended.

 

“Series” or “Series of
Securities” means each series of debentures, notes or other debt instruments of the Company created pursuant to Sections 2.1
and 2.2.

 

“Significant Subsidiary” means
(i) any direct or indirect Subsidiary of the Company that would be a “significant subsidiary” as defined in Article 1,
Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the date
hereof, or (ii) any group of direct or indirect Subsidiaries of the Company that, taken together as a group, would be a “significant
subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act,
as such regulation is in effect on the date hereof.

 

“Stated Maturity,” when used
with respect to any Security or any installment of principal thereof or interest thereon, means the date specified in such Security
as the fixed date on which the principal of such Security and the interest thereon, or such installment of principal or interest,
is due and payable, and when used with respect to any other Indebtedness, means the date specified in the instrument governing
such Indebtedness as the fixed date on which the principal of such Indebtedness, or any installment of interest thereon, is due
and payable.

 

“Subsidiary” of any specified
Person means any corporation, limited liability company, partnership, joint venture, association or other business entity, whether
now existing or hereafter organized or acquired, (i) in the case of a corporation, of which more than 50% of the total voting
power of the Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors
thereof is held, directly or indirectly, by such Person or any of its Subsidiaries; or (ii) in the case of a partnership,
joint venture, association or other business entity, with respect to which such Person or any of its Subsidiaries has the power
to direct or cause the direction of the management and policies of such entity by contract or otherwise, or if in accordance with
GAAP such entity is consolidated with such Person for financial statement purposes.

 

“TIA” means the Trust Indenture
Act of 1939 (15 U.S. Code Section 77aaa-77bbbb) as in effect on the date of this Indenture (except as provided in Section 8.3).

 

“Trustee” means the party named
as such in this Indenture until a successor replaces it pursuant to this Indenture, and thereafter means the successor, and if
at any time there is more than one such Person, “Trustee” as used with respect to the Securities of any Series shall
mean the Trustee with respect to Securities of that Series.

 

“U.S. Government Obligations”
means direct non-callable obligations of, or non-callable obligations guaranteed by, the United States of America for the payment
of which obligation or guarantee the full faith and credit of the United States of America is pledged.

 

    3

     

    

 

1.2. OTHER DEFINITIONS.

 

The definitions of the following terms
may be found in the sections indicated as follows:

 

	TERM	 	DEFINED IN SECTION
	“Bankruptcy Law”	 	6.1
	 	 
	“Business Day”	 	10.7
	 	 
	“Covenant Defeasance”	 	9.3
	 	 
	“Custodian”	 	6.1
	 	 
	“Event of Default”	 	6.1
	 	 
	“Journal”	 	10.15
	 	 
	“Judgment Currency”	 	10.16
	 	 
	“Legal Defeasance”	 	9.2
	 	 
	“Legal Holiday”	 	10.7
	 	 
	“Market Exchange Rate”	 	10.15
	 	 
	“New York Paying Agent”	 	2.4
	 	 
	“Paying Agent”	 	2.4
	 	 
	“Place of Payment”	 	10.7
	 	 
	“Registrar”	 	2.4
	 	 
	“Required Currency”	 	10.16
	 	 
	“Service Agent”	 	2.4

 

1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT.

 

Whenever this Indenture refers to a provision
of the TIA, the portion of such provision required to be incorporated herein in order for this Indenture to be qualified under
the TIA is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have
the following meanings:

 

“Commission” means the SEC.

 

“Indenture securities” means
the Securities.

 

“Indenture securityholder”
means a Holder or Securityholder.

 

“Indenture to be qualified”
means this Indenture.

 

“Indenture trustee” or “institutional
trustee” means the Trustee.

 

“Obligor on the indenture securities”
means the Company or any other obligor on the Securities.

 

All other terms used in this Indenture
that are defined by the TIA, defined in the TIA by reference to another statute or defined by SEC rule have the meanings therein
assigned to them.

 

    4

     

    

 

1.4. RULES OF CONSTRUCTION.

 

Unless the context otherwise requires:

 

(1) a term has the meaning assigned to
it herein, whether defined expressly or by reference;

 

(2) unless otherwise specified herein,
all accounting terms used herein shall be interpreted, all accounting determinations hereunder shall be made, and all financial
statements required to be delivered hereunder shall be prepared in accordance with GAAP;

 

(3) “or” is not exclusive;

 

(4) words in the singular include the
plural, and in the plural include the singular;

 

(5) words used herein implying any gender
shall apply to each gender;

 

(6) the words “herein”, “hereof”
and “hereunder” and other words of similar import refer to this Indenture as a whole and not to any particular Article,
Section or other subdivision; and

 

(7) “$,” refers to Dollars,
or such other money of the United States that at the time of payment is legal tender for payment of public and private debts.

 

ARTICLE 2 –

THE SECURITIES

 

2.1. ISSUABLE IN SERIES.

 

The aggregate principal amount of Securities
that may be authenticated and delivered under this Indenture is $            ,
             ,             .
The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth
in a Board Resolution, a supplemental indenture or an Officers’ Certificate detailing the adoption of the terms thereof pursuant
to the authority granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time, the
Board Resolution, Officers’ Certificate or supplemental indenture may provide for the method by which specified terms (such
as interest rate, Stated Maturity, record date or date from which interest shall accrue) are to be determined. Securities may differ
between Series in respect of any matters, PROVIDED, that all Series of Securities shall be equally and ratably entitled
to the benefits of the Indenture.

 

2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES.

 

At or prior to the issuance of any Securities
within a Series, the following shall be established (as to the Series generally, in the case of Subsection 2.2(1) and
either as to such Securities within the Series or as to the Series generally in the case of Subsections 2.2(2) through
2.2(24)) by a Board Resolution, a supplemental indenture or an Officers’ Certificate, in each case, pursuant to authority
granted under a Board Resolution:

 

(1) the title of the Series (which
shall distinguish the Securities of that particular Series from the Securities of any other Series);

 

(2) any limit upon the aggregate principal
amount of the Securities of the Series which may be authenticated and delivered under this Indenture (except for Securities
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series pursuant
to Section 2.7, 2.8, 2.11, 3.6 or 8.5);

 

(3) the price or prices (expressed as
a percentage of the principal amount thereof) at which the Securities of the Series will be issued;

 

(4) the date or dates on which the principal
of the Securities of the Series is payable;

 

(5) the rate or rates (which may be fixed
or variable) per annum or, if applicable, the method used to determine such rate or rates (including, but not limited to, any commodity,
commodity index, stock exchange index or financial index) at which the Securities of the Series shall bear interest, if any,
the date or dates from which such interest, if any, shall accrue, the date or dates on which such interest, if any, shall commence
and be payable and any regular record date for the interest payable on any Interest Payment Date;

 

    5

     

    

 

(6) the place or places where the principal
of, and interest and premium, if any, on, the Securities of the Series shall be payable, or the method of such payment, if
by wire transfer, mail or other means;

 

(7) if applicable, the period or periods
within which, the price or prices at which and the terms and conditions upon which the Securities of the Series may be redeemed,
in whole or in part, at the option of the Company;

 

(8) the obligation, if any, of the Company
to redeem or purchase the Securities of the Series pursuant to any sinking fund or analogous provisions or at the option of
a Holder thereof, and the period or periods within which, the price or prices at which and

the terms and conditions upon which Securities of the Series shall
be redeemed or purchased, in whole or in part, pursuant to such obligation;

 

(9) the dates, if any, on which and the
price or prices at which the Securities of the Series will be repurchased by the Company at the option of the Holders thereof,
and other detailed terms and provisions of such repurchase obligations;

 

(10) if other than denominations of $1,000
and any integral multiple thereof, the denominations in which the Securities of the Series shall be issuable;

 

(11) the forms of the Securities of the
Series in bearer (if to be issued outside of the United States of America) or fully registered form (and, if in fully registered
form, whether the Securities will be issuable as Global Securities);

 

(12) if other than the principal amount
thereof, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration of acceleration
of the Maturity thereof pursuant to Section 6.2;

 

    6

     

    

 

 

(13) the currency of denomination of the
Securities of the Series, which may be Dollars or any Foreign Currency, including, but not limited to, the Euro, and, if such currency
of denomination is a composite currency other than the Euro, the agency or organization, if any, responsible for overseeing such
composite currency;

 

(14) the designation of the currency,
currencies or currency units in which payment of the principal of, and interest and premium, if any, on, the Securities of the
Series will be made;

 

(15) if payments of principal of, or interest
or premium, if any, on, the Securities of the Series are to be made in one or more currencies or currency units other than
that or those in which such Securities are denominated, the manner in which the exchange rate with respect to such payments will
be determined;

 

(16) the manner in which the amounts of
payment of principal of, or interest and premium, if any, on, the Securities of the Series will be determined, if such amounts
may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock
exchange index or financial index;

 

(17) the provisions, if any, relating
to any collateral provided for the Securities of the Series;

 

(18) any addition to or change in the
covenants set forth in Articles 4 or 5 that applies to Securities of the Series;

 

(19) any addition to or change in the
Events of Default which applies to any Securities of the Series, any provision for the payment of additional interest or liquidated
damages in connection with any Event of Default, and any change in the right of the Trustee or the requisite Holders of such Securities
to declare the principal amount thereof due and payable pursuant to Section 6.2;

 

(20) the terms and conditions, if any,
for conversion of the Securities into or exchange of the Securities for shares of common stock, preferred stock, other debt securities,
or warrants, subscription rights or units for common stock, preferred stock or other securities of any kind of the Company that
apply to Securities of the Series;

 

(21) any Trustees, depositories, interest
rate calculation agents, exchange rate calculation agents or other agents with respect to Securities of such Series if other
than those appointed herein;

 

(22) the terms and conditions, if any,
upon which the Securities shall be subordinated in right of payment to other Indebtedness of the Company;

 

(23) if applicable, that the Securities
of the Series, in whole or any specified part, shall be defeasible pursuant to Article 9; and

 

(24) any other terms of the Securities
of the Series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 8.1,
but which may modify or delete any provision of this Indenture insofar as it applies to such Series).

 

All Securities of any one Series need
not be issued at the same time, and may be issued from time to time, consistent with the terms of this Indenture, if so provided
by or pursuant to the Board Resolution, supplemental indenture or Officers’ Certificate referred to above, however, the authorized
principal amount of any Series may not be increased to provide for issuances of additional Securities of such Series, unless
otherwise provided in such Board Resolution, supplemental indenture or Officers’ Certificate.

 

    7

     

    

 

2.3. EXECUTION AND AUTHENTICATION.

 

The Securities shall be executed on behalf
of the Company by two Officers of the Company or an Officer and an Assistant Secretary of the Company. Each such signature may
be either manual or facsimile. The Company’s seal may be impressed, affixed, imprinted or reproduced on the Securities and
may be in facsimile form.

 

If an Officer whose signature is on a Security
no longer holds that office at the time the Security is authenticated, the Security shall nevertheless be valid.

 

A Security shall not be valid until authenticated
by the manual signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence that the Security
has been authenticated under this Indenture. The Trustee shall at any time, and from time to time, authenticate Securities for
original issue in the principal amount provided in the Board Resolution, supplemental indenture hereto or Officers’ Certificate,
upon receipt by the Trustee of a Company Order. Such Company Order may authorize authentication and delivery pursuant to oral or
electronic instructions from the Company or its duly authorized agent or agents, which oral instructions shall be promptly confirmed
in writing. Each Security shall be dated the date of its authentication.

 

The aggregate principal amount of Securities
of any Series outstanding at any time may not exceed any limit upon the maximum principal amount for such Series set
forth in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.2,
except as provided in Section 2.8.

 

Prior to the issuance of Securities of
any Series, the Trustee shall have received and (subject to Section 7.1) shall be fully protected in relying on: (a) the
Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the form of the Securities of that
Series or of Securities within that Series and the terms of the Securities of that Series or of Securities within
that Series, (b) an Officers’ Certificate complying with Section 10.4, and (c) an Opinion of Counsel complying
with Section 10.4.

 

The Trustee shall have the right to decline
to authenticate and deliver any Securities of any Series: (a) if the Trustee, being advised in writing by outside counsel,
determines that such action may not lawfully be taken; or (b) if the Trustee in good faith by its board of directors or trustees,
executive committee or a trust committee of directors and/or vice-presidents shall reasonably determine that such action would
expose the Trustee to personal liability, or cause it to have a conflict of interest with respect to Holders of any then outstanding
Series of Securities.

 

The Trustee may appoint an authenticating
agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate Securities whenever the Trustee
may do so. Any appointment shall be evidenced by an instrument signed by an authorized officer of the Trustee, a copy of which
shall be furnished to the Company. Each reference in this Indenture to authentication by the Trustee includes authentication by
such agent. An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate of the Company.

 

2.4. REGISTRAR AND PAYING AGENT.

 

The Company shall maintain in each Place
of Payment for any Series of Securities (i) an office or agency where such Securities may be presented for registration
of transfer or for exchange (“Registrar”), (ii) an office or agency where such Securities may be presented for
payment (“Paying Agent”),and PROVIDED, that at the option of the Company payment of interest may be made by check mailed
to the address of the Person entitled thereto as such address shall appear in the register for the Securities maintained by the
Registrar), and (iii) an office or agency where notices and demands to or upon the Company in respect of the Securities and
this Indenture may be served (“Service Agent”). The Registrar shall keep a register of the Securities and of their
transfer and exchange. The Company may have one or more co-Registrars and Service Agents and one or more additional Paying Agents.
The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or
agency. If at any time the Company shall fail to maintain any such required office, or to furnish the Trustee with the address
thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee as set forth in
Section 10.2. The Company or any of its Subsidiaries may also act as Paying Agent. If the Company acts as Paying Agent, it
shall segregate the money held by it for the payment of principal of, and interest and premium, if any, on, the Securities and
hold it as a separate trust fund. The Company may change any Paying Agent, Registrar, co-registrar, Service Agent or any other
Agent without notice to any Securityholder.

 

The Company may also from time to time
designate one or more other offices or agencies where the Securities may be presented or surrendered for any or all such purposes,
and may from time to time rescind such designations; PROVIDED, HOWEVER, that no such designation or rescission shall in any manner
relieve the Company of its obligation to maintain an office or agency in each Place of Payment for Securities of any Series for
such purposes. The Company hereby initially designates the Corporate Trust Office of the Trustee as such office of the Company.
The Company shall give prompt written notice to the Trustee of such designation or rescission, and of any change in the location
of any such other office or agency.

 

The Company shall enter into an
appropriate agency agreement with any Registrar, Paying Agent or Service Agent not a party to this Indenture. The agreement
shall implement the provisions of this Indenture that relate to such Agent. The Company shall notify the Trustee of the name
and address of any such Agent. If the Company fails to maintain a Registrar, Paying Agent, or Service Agent and demands, or
fails to give the foregoing notice, the Trustee shall act as such. The Company hereby appoints the Trustee as the initial
Registrar, Paying Agent and Service Agent for each Series unless another Registrar, Paying Agent or Service Agent, as
the case may be, is appointed prior to the time Securities of that Series are first issued. The Company designates, as
the New York Paying Agent, with offices at:  .

 

    8

     

    

 

2.5. PAYING AGENT TO HOLD ASSETS IN TRUST.

 

The Trustee as Paying Agent shall, and
the Company shall require each Paying Agent other than the Trustee to agree in writing that each Paying Agent shall, hold in trust
for the benefit of the Holders of any Series of Securities or the Trustee all assets held by the Paying Agent for the payment
of principal of, or interest or premium, if any, on, such Series of Securities (whether such assets have been distributed
to it by the Company or any other obligor on such Series of Securities), and the Company and the Paying Agent shall notify
the Trustee in writing of any Default by the Company (or any other obligor on such Series of Securities) in making any such
payment. The Company at any time may require a Paying Agent to distribute all assets held by it to the Trustee and account for
any assets disbursed, and the Trustee may, at any time during the continuance of any payment default with respect to any Series of
Securities, upon written request to a Paying Agent, require such Paying Agent to distribute all assets held by it to the Trustee
and to account for any assets distributed. Upon distribution to the Trustee of all assets that shall have been delivered by the
Company to the Paying Agent, the Paying Agent shall have no further liability for such assets.

 

2.6. SECURITYHOLDER LISTS.

 

The Trustee shall preserve in as current
a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders of each
Series of Securities. If the Trustee is not the Registrar, the Company shall furnish to the Trustee as of each regular record
date for the payment of interest on the Securities of a Series and before each related Interest Payment Date, and at such
other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require
of the names and addresses of Securityholders of each Series of Securities.

 

2.7. TRANSFER AND EXCHANGE.

 

When Securities of a Series are presented
by the Holder to the Registrar with a request to register the transfer thereof, the Registrar shall register the transfer as requested
if the requirements of applicable law are met, and when such Securities of a Series are presented to the Registrar with a
request to exchange them for an equal principal amount of other authorized denominations of Securities of the same Series, the
Registrar shall make the exchange as requested. To permit transfers and exchanges, upon surrender of any Security for registration
of transfer at the office or agency maintained pursuant to Section 2.4, the Company shall execute and the Trustee shall authenticate
Securities at the Registrar’s request.

 

If Securities are issued as Global Securities,
the provisions of Section 2.15 shall apply.

 

All Securities issued upon any registration
of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing the same debt, and entitled to
the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange.

 

Every Security presented or surrendered
for registration of transfer or for exchange shall (if so required by the Company or the Registrar or a co-registrar) be duly endorsed,
or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar or a co-registrar,
duly executed by the Holder thereof or his attorney duly authorized in writing.

 

Any exchange or transfer shall be without
charge, except that the Company may require payment by the Holder of a sum sufficient to cover any tax or other governmental charge
that may be imposed in relation to a transfer or exchange, but this provision shall not apply to any exchange pursuant to Section 2.11,
3.6 or 8.5. The Trustee shall not be required to register transfers of Securities of any Series, or to exchange Securities of any
Series, for a period of 15 days before the record date for selection for redemption of such Securities. The Trustee shall
not be required to exchange or register transfers of Securities of any Series called or being called for redemption in whole
or in part, except the unredeemed portion of such Security being redeemed in part.

 

    9

     

    

 

2.8. REPLACEMENT SECURITIES.

 

If a mutilated Security is
surrendered to the Trustee, or if the Holder of a Security presents evidence to the satisfaction of the Company and the
Trustee that the Security has been lost, destroyed or wrongfully taken, the Company shall issue and the Trustee shall
authenticate a replacement Security of the same Series and of like tenor and principal amount and bearing a number not
contemporaneously outstanding. An indemnity bond may be required by the Company or the Trustee that is sufficient in the
reasonable judgment of the Company or the Trustee, as the case may be, to protect the Company, the Trustee or any Agent from
any loss which any of them may suffer if a Security is replaced. The Company may charge such Holder for the Company’s
out-of-pocket expenses in replacing a Security, including the fees and expenses of the Trustee. Every replacement Security
shall constitute an original additional obligation of the Company, whether or not the destroyed, lost or stolen Security
shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and
proportionately with any and all other Securities of that Series duly issued hereunder.

 

2.9. OUTSTANDING SECURITIES.

 

Securities outstanding at any time are
all Securities authenticated by the Trustee, except for those canceled by it, those delivered to it for cancellation and those
described in this Section 2.9 as not outstanding.

 

If a Security is replaced pursuant to Section 2.8
(other than a mutilated Security surrendered for replacement), it ceases to be outstanding until the Company and the Trustee receive
proof satisfactory to each of them that the replaced Security is held by a bona fide purchaser. A mutilated Security ceases to
be outstanding upon surrender of such Security and replacement thereof pursuant to Section 2.8.

 

If a Paying Agent holds on a Redemption
Date or the Stated Maturity money sufficient to pay the principal of, premium, if any, and accrued interest on, Securities payable
on that date, and is not prohibited from paying such money to the Holders thereof pursuant to the terms of this Indenture (PROVIDED,
that if such Securities are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision
therefor satisfactory to the Trustee has been made), then on and after that date and upon payment of such money to the Holder,
such Securities will be cancelled and cease to be outstanding and interest on them ceases to accrue.

 

A Security does not cease to be outstanding
solely because the Company or an Affiliate holds the Security.

 

2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION
OF HOLDERS’ ACTION.

 

In determining whether the Holders of the
required aggregate principal amount of the Securities of any Series have concurred in any direction, waiver or consent, the
Securities of any Series owned by the Company or any other obligor on such Securities, or by any Affiliate of any of them,
shall be disregarded, except that for the purposes of determining whether the Trustee shall be protected in relying on any such
direction, waiver or consent, only Securities of such Series which the Trustee actually knows are so owned shall be so disregarded.
Securities of such Series so owned which have been pledged in good faith shall not be disregarded if the pledgee establishes
to the satisfaction of the Trustee the pledgee’s right so to act with respect to the Securities of such Series and that
the pledgee is not the Company or any other obligor on the Securities of such Series, or an Affiliate of any of them.

 

2.11. TEMPORARY SECURITIES.

 

Until definitive Securities are ready for
delivery, the Company may prepare and execute, and the Trustee shall authenticate, temporary Securities. Temporary Securities shall
be substantially in the form, and shall carry all rights, of definitive Securities, but may have variations that the Company considers
appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and execute, and the Trustee shall
authenticate, definitive Securities in exchange for temporary Securities without charge to the Holder.

 

    10

     

    

 

2.12. CANCELLATION.

 

All Securities surrendered for payment,
redemption or registration of transfer or exchange, or for credit against any sinking fund payment, shall, if surrendered to any
Person other than the Trustee, be delivered to the Trustee for cancellation. The Company may at any time deliver to the Trustee
for cancellation any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner
whatsoever, and may deliver to the Trustee (or to any other Person for delivery to the Trustee) for cancellation any Securities
previously authenticated hereunder which the Company has not issued and sold. The Registrar and the Paying Agent shall forward
to the Trustee any Securities surrendered to them for transfer, exchange or payment. The Trustee or, at the direction of the Trustee,
the Registrar or the Paying Agent, and no one else, shall cancel, and at the written request of the Company shall dispose of, all
Securities surrendered for transfer, exchange, payment or cancellation. If the Company shall acquire any of the Securities, such
acquisition shall not operate as a redemption or satisfaction of the Indebtedness represented by such Securities unless and until
the same are surrendered to the Trustee for cancellation pursuant to this Section 2.12. No Securities shall be authenticated
in lieu of or in exchange for any Securities cancelled as provided in this Section 2.12, except as expressly permitted by
this Indenture.

 

2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION
OF INTEREST.

 

Except as otherwise provided as contemplated
by Section 2.2 with respect to any Series of Securities, interest on any Security which is payable, and is punctually
paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name that Security is registered at
the close of business on the regular record date for such interest, as provided in the Board Resolution, supplemental indenture
hereto or Officers’ Certificate establishing the terms of such Series.

 

If the Company defaults in a payment of
interest on the Securities, it shall pay the defaulted amounts, plus any interest payable on defaulted amounts pursuant to Section 4.1,
to the Persons who are Securityholders on a subsequent special record date, which date shall be the 15th day next preceding the
date fixed by the Company for the payment of defaulted interest, or the next succeeding Business Day if such date is not a Business
Day. At least 15 days before the special record date, the Company shall mail or cause to be mailed to each Securityholder,
with a copy to the Trustee, a notice that states the special record date, the payment date and the amount of defaulted interest,
and interest payable on such defaulted interest, if any, to be paid.

 

Except as otherwise specified as contemplated
by Section 2.2 for Securities of any Series, interest on the Securities of each Series shall be computed on the basis
of a 360-day year of twelve 30-day months.

 

2.14. CUSIP NUMBER.

 

The Company in issuing the Securities may
use one or more “CUSIP” numbers, and, if the Company does so, the Trustee shall use the CUSIP number(s) in notices
of redemption or exchange as a convenience to Holders, PROVIDED, that any such notice may state that no representation is made
as to the correctness or accuracy of the CUSIP number(s) printed in the notice or on the Securities, and that reliance may
be placed only on the other identification numbers printed on the Securities, and that any such redemption or exchange shall not
be affected by any defect in or omission of any such numbers.

 

    11

     

    

 

2.15. PROVISIONS FOR GLOBAL SECURITIES.

 

(a) A Board Resolution, a supplemental
indenture hereto or an Officers’ Certificate shall establish whether the Securities of a Series shall be issued in whole
or in part in the form of one or more Global Securities, and the Depository for such Global Securities or Securities.

 

(b) Notwithstanding any provisions to the
contrary contained in Section 2.7 and in addition thereto, if, and only if the Depository (i) at any time is unwilling
or unable to continue as Depository for such Global Security or ceases to be a clearing agency registered under the Exchange Act
and (ii) a successor Depository is not appointed by the Company within 90 days after the date the Company is so informed
in writing or becomes aware of the same, the Company promptly will execute and deliver to the Trustee definitive Securities, and
the Trustee, upon receipt of a Company Request for the authentication and delivery of such definitive Securities (which the Company
will promptly execute and deliver to the Trustee) and an Officers’ Certificate to the effect that such Global Security shall
be so exchangeable, will authenticate and deliver definitive Securities, without charge, registered in such names and in such authorized
denominations as the Depository shall direct in writing (pursuant to instructions from its direct and indirect participants or
otherwise) in an aggregate principal amount equal to the principal amount of the Global Security with like tenor and terms. Upon
the exchange of a Global Security for definitive Securities, such Global Security shall be canceled by the Trustee. Unless and
until it is exchanged in whole or in part for definitive Securities, as provided in this Section 2.15(b), a Global Security
may not be transferred except as a whole by the Depository with respect to such Global Security to a nominee of such Depository,
by a nominee of such Depository to such Depository or another nominee of such Depository or by the Depository or any such nominee
to a successor Depository or a nominee of such a successor Depository.

 

(c) Any Global Security issued hereunder
shall bear a legend in substantially the following form:

 

“This Security is a Global Security within
the meaning of the Indenture hereinafter referred to, and is registered in the name of the Depository or a nominee of the Depository.
This Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in
the limited circumstances described in the Indenture, and may not be transferred except as a whole by the Depository to a nominee
of the Depository, by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or
any such nominee to a successor Depository or a nominee of such a successor Depository.”

 

(d) The Depository, as a Holder, may appoint
agents and otherwise authorize participants to give or take any request, demand, authorization, direction, notice, consent, waiver
or other action which a Holder is entitled to give or take under the Indenture.

 

(e) Notwithstanding the other provisions
of this Indenture, unless otherwise specified as contemplated by Section 2.2, payment of the principal of, and interest and
premium, if any, on, any Global Security shall be made to the Depository or its nominee in its capacity as the Holder thereof.

 

(f) Except as provided in Section 2.15(e) above,
the Company, the Trustee and any Agent shall treat a Person as the Holder of such principal amount of outstanding Securities of
any Series represented by a Global Security as shall be specified in a written statement of the Depository (which may be in
the form of a participants’ list for such Series) with respect to such Global Security, for purposes of obtaining any consents,
declarations, waivers or directions required to be given by the Holders pursuant to this Indenture, PROVIDED, that until the Trustee
is so provided with a written statement, it may treat the Depository or any other Person in whose name a Global Security is registered
as the owner of such Global Security for the purpose of receiving payment of the principal of, and any premium and (subject to
Section 2.13) any interest on, such Global Security and for all other purposes whatsoever, and none of the Company, the Trustee
or any agent of the Company or the Trustee shall be affected by notice to the contrary.

 

2.16. PERSONS DEEMED OWNERS.

 

Prior to due presentment of a Security
for registration of transfer, the Company, the Trustee, the Registrar and any agent of the Company, the Registrar or the Trustee
may treat the Person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment
of the principal of, and any premium and (subject to Section 2.13) any interest on, such Security and for all other purposes
whatsoever, and none of the Company, the Trustee, the Registrar or any agent of the Company, the Trustee or the Registrar shall
be affected by notice to the contrary.

 

    12

     

    

 

ARTICLE 3 –

REDEMPTION

 

3.1. NOTICES TO TRUSTEE.

 

The Company may, with respect to any Series of
Securities, reserve the right to redeem and pay the Series of Securities, or may covenant to redeem and pay the Series of
Securities or any part thereof, prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities
or the related Board Resolution, supplemental indenture or Officers’ Certificate. If a Series of Securities is redeemable
and the Company elects to redeem all or part of such Series of Securities, it shall notify the Trustee of the Redemption Date
and the principal amount of Securities to be redeemed at least 45 days (unless a shorter notice shall be satisfactory to the
Trustee) before the Redemption Date. Any such notice may be canceled at any time prior to notice of such redemption being mailed
to any Holder, and shall thereby be void and of no effect.

 

3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED.

 

Unless otherwise indicated for a particular
Series of Securities by a Board Resolution, a supplemental indenture or an Officers’ Certificate, if fewer than all
of the Securities of a Series are to be redeemed, the Trustee shall select the Securities of a Series to be redeemed
pro rata, by lot or by any other method that the Trustee considers fair and appropriate (unless the Company specifically directs
the Trustee otherwise) and, if such Securities are listed on any securities exchange, by a method that complies with the requirements
of such exchange.

 

The Trustee shall make the selection from
Securities of a Series outstanding and not previously called for redemption, and shall promptly notify the Company in writing
of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount
thereof to be redeemed at least 35 but not more than 60 days before the Redemption Date. Securities of a Series in denominations
of $1,000 may be redeemed only in whole. The Trustee may select for redemption portions of the principal of Securities of a Series that
have denominations larger than $1,000. Securities of a Series and portions of them it selects shall be in amounts of $1,000
or, with respect to Securities of any Series issuable in other denominations pursuant to Section 2.2(10), the minimum
principal denomination for each Series and integral multiples thereof. Provisions of this Indenture that apply to Securities
called for redemption also apply to portions of Securities called for redemption.

 

3.3. NOTICE OF REDEMPTION.

 

Unless otherwise indicated for a particular
Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, at least 30 days, and
no more than 60 days, before a Redemption Date, the Company shall mail, or cause to be mailed, a notice of redemption by first-class
mail to each Holder of Securities to be redeemed at his or her last address as the same appears on the registry books maintained
by the Registrar. The notice shall identify the Securities to be redeemed and shall state:

 

(1) the Redemption Date;

 

(2) the redemption price, and that such
redemption price shall become due and payable on the Redemption Date;

 

(3) if any Security of a Series is
being redeemed in part, the portion of the principal amount of such Security of a Series to be redeemed and that, after the
Redemption Date and upon surrender of such Security of a Series, a new Security or Securities in principal amount equal to the
unredeemed portion will be issued;

 

(4) the name and address of the Paying
Agent;

 

(5) that Securities of a Series called
for redemption must be surrendered to the Paying Agent to collect the redemption price, and the place or places where each such
Security is to be surrendered for such payment;

 

(6) that, unless the Company defaults
in making the redemption payment, interest on the Securities of a Series called for redemption ceases to accrue on the Redemption
Date, and the only remaining right of the Holders of such Securities is to receive payment of the redemption price upon surrender
to the Paying Agent of the Securities redeemed;

 

(7) if fewer than all of the Securities
of a Series are to be redeemed, the identification of the particular Securities of a Series (or portion thereof) to be
redeemed, as well as the aggregate principal amount of Securities of a Series to be redeemed and the aggregate principal amount
of Securities of a Series to be outstanding after such partial redemption.

 

(8) the CUSIP number, if any, printed
on the Securities being redeemed; and

 

(9) that no representation is made as
to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Securities.

 

At the Company’s request, the Trustee
shall give the notice of redemption in the Company’s name and at the Company’s sole expense.

 

    13

     

    

 

3.4. EFFECT OF NOTICE OF REDEMPTION.

 

Once the notice of redemption described
in Section 3.3 is mailed, Securities of a Series called for redemption become due and payable on the Redemption Date
and at the redemption price, plus interest, if any, accrued to the Redemption Date. Upon surrender to the Trustee or Paying Agent,
such Securities of a Series shall be paid at the redemption price, plus accrued interest, if any, to the Redemption Date;
PROVIDED, that if the Redemption Date is after a regular interest payment record date and on or prior to the next Interest Payment
Date, the accrued interest shall be payable to the Holder of the redeemed Securities registered on the relevant record date, as
specified by the Company in the notice to the Trustee pursuant to Section 3.1.

 

3.5. DEPOSIT OF REDEMPTION PRICE.

 

On or prior to the Redemption Date (but
no later than 11:00 A.M. Eastern Time on such date), the Company shall deposit with the Paying Agent money sufficient to pay
the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date other than Securities or portions
thereof called for redemption on that date which have been delivered by the Company to the Trustee for cancellation.

 

On and after any Redemption Date, if money
sufficient to pay the redemption price of, and accrued interest on, Securities called for redemption shall have been made available
in accordance with the preceding paragraph and the Company and the Paying Agent are not prohibited from paying such moneys to Holders,
the Securities called for redemption will cease to accrue interest and the only right of the Holders of such Securities will be
to receive payment of the redemption price of and, subject to the proviso in Section 3.4, accrued and unpaid interest on such
Securities to the Redemption Date. If any Security called for redemption shall not be so paid, interest will be paid, from the
Redemption Date until such redemption payment is made, on the unpaid principal of the Security and any interest or premium, if
any, not paid on such unpaid principal, in each case, at the rate and in the manner provided in the Securities.

 

3.6. SECURITIES REDEEMED IN PART.

 

Upon surrender of a Security of a Series that
is redeemed in part, the Company shall execute, and the Trustee shall authenticate, for a Holder a new Security of the same Series equal
in principal amount to the unredeemed portion of the Security surrendered.

 

    14

     

    

 

ARTICLE 4 –

COVENANTS

 

4.1. PAYMENT OF SECURITIES.

 

The Company shall pay the principal of,
and interest and premium, if any, on, each Series of Securities on the dates and in the manner provided in such Securities
and this Indenture.

 

An installment of principal or interest
shall be considered paid on the date it is due if the Trustee or Paying Agent holds on that date money designated for and sufficient
to pay such installment and is not prohibited from paying such money to the Holders pursuant to the terms of this Indenture or
otherwise.

 

The Company shall pay interest on overdue
principal, and overdue interest, to the extent lawful, at the rate specified in the Series of Securities.

 

4.2. SEC REPORTS.

 

The Company will deliver to the Trustee
within 15 days after the filing of the same with the SEC, copies of the quarterly and annual reports and of the information,
documents and other reports, if any, which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of
the Exchange Act; PROVIDED, HOWEVER, that each such report or document will be deemed to be so delivered to the Trustee if the
Company files such report or document with the SEC through the SEC’s EDGAR database no later than the time such report or
document is required to be filed with the SEC pursuant to the Exchange Act. Notwithstanding that the Company may not be subject
to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company will file with the SEC, to the
extent permitted, and provide the Trustee with, such quarterly and annual reports and such information, documents and other reports
specified in Sections 13 and 15(d) of the Exchange Act. The Company will also comply with the other provisions of TIA
Section 314(a).

 

4.3. WAIVER OF STAY, EXTENSION OR USURY LAWS.

 

The Company covenants (to the extent that
it may lawfully do so) that it will not at any time insist upon, or plead (as a defense or otherwise) or in any manner whatsoever
claim or take the benefit or advantage of, any stay, extension, usury or other law which would prohibit or forgive the Company
from paying all or any portion of the principal of, and/or interest and premium, if any, on, the Securities as contemplated herein,
wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Indenture;
and the Company hereby expressly waives (to the extent that they may lawfully do so) all benefit or advantage of any such law,
and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer
and permit the execution of every such power as though no such law had been enacted.

 

4.4. COMPLIANCE CERTIFICATE.

 

(a) The Company shall deliver to the Trustee,
within 120 days after the end of each fiscal year of the Company, an Officers’ Certificate which complies with TIA Section 314(a)(4) stating
that a review of the activities of the Company and its Subsidiaries during such fiscal year has been made under the supervision
of the signing Officers with a view to determining whether the Company has kept, observed, performed and fulfilled its obligations
under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or her knowledge
the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and that there is no
default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default
shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the
Company is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has occurred
and remains in existence by reason of which payments on account of the principal of, or interest or premium, if any, on, the Securities
is prohibited, or if such event has occurred, a description of the event and what action the Company is taking or proposes to take
with respect thereto.

 

(b)(i) If any Default or Event of
Default has occurred and is continuing or (ii) if any Holder seeks to exercise any remedy hereunder with respect to a claimed
Default under this Indenture or the Securities, within five Business Days after the Company becoming aware of such occurrence the
Company shall deliver to the Trustee an Officers’ Certificate specifying such event, notice or other action and what action
the Company is taking or proposes to take with respect thereto.

 

4.5. CORPORATE EXISTENCE.

 

Subject to Article 5, the
Company shall do or cause to be done all things necessary to preserve and keep in full force and effect its corporate
existence, in accordance with the organizational documents (as the same may be amended from time to time) of the Company and
the rights (charter and statutory), licenses and franchises of the Company; PROVIDED, HOWEVER, that the Company shall not be
required to preserve any such right, license or franchise, or its corporate existence, if the Board of Directors shall
determine that the preservation thereof is no longer desirable in the conduct of the business of the Company and that the
loss thereof is not adverse in any material respect to the Holders.

 

    15

     

    

 

ARTICLE 5 –

SUCCESSOR CORPORATION

 

5.1. LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS.

 

(a) The Company will not, in any transaction
or series of transactions, merge or consolidate with or into, or sell, assign, convey, transfer, lease or otherwise dispose of
all or substantially all of its properties and assets (as an entirety or substantially as an entirety in one transaction or a series
of related transactions), to any Person or Persons, unless at the time of and after giving effect thereto (i) either (A) if
the transaction or series of transactions is a merger or consolidation, the Company shall be the surviving Person of such merger
or consolidation, or (B) the Person formed by such consolidation or into which the Company is merged or to which the properties
and assets of the Company are transferred (any such surviving Person or transferee Person being the “Surviving Entity”)
shall be a corporation organized and existing under the laws of the United States of America, any state thereof or the District
of Columbia, or a corporation or comparable legal entity organized under the laws of a foreign jurisdiction and shall expressly
assume by a supplemental indenture executed and delivered to the Trustee, in form reasonably satisfactory to the Trustee, all of
the obligations of the Company (including, without limitation, the obligation to pay the principal of, and premium and interest,
if any, on, the Securities and the performance of the other covenants) under the Securities of each Series and this Indenture,
and in each case, this Indenture shall remain in full force and effect; and (ii) immediately before and immediately after
giving effect to such transaction or series of transactions on a pro forma basis (including, without limitation, any Indebtedness
incurred or anticipated to be incurred in connection with or in respect of such transaction or series of transactions), no Default
or Event of Default shall have occurred and be continuing.

 

(b) In connection with any
consolidation, merger or transfer of assets contemplated by this Section 5.1, the Company shall deliver, or cause to be
delivered, to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers’ Certificate and
an Opinion of Counsel, each stating that such consolidation, merger or transfer, and the supplemental indenture in respect
thereto, comply with this Section 5.1, and that all conditions precedent herein provided for relating to such
transaction or transactions have been complied with.

 

5.2. SUCCESSOR PERSON SUBSTITUTED.

 

Upon any consolidation, merger or transfer
of all or substantially all of the assets of the Company in accordance with Section 5.1 above, the successor corporation formed
by such consolidation, or into which the Company is merged or to which such transfer is made, shall succeed to, and be substituted
for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor corporation
had been named as the Company herein, and thereafter (except with respect to any such transfer which is a lease) the predecessor
corporation shall be relieved of all obligations and covenants under this Indenture and the Securities.

 

    16

     

    

 

ARTICLE 6 –

DEFAULTS AND REMEDIES

 

6.1. EVENTS OF DEFAULT.

 

An “Event of Default,” wherever
used herein with respect to Securities of any Series, means any one of the following events, unless in the establishing Board Resolution,
supplemental indenture or Officers’ Certificate, it is provided that such Series shall not have the benefit of said
Event of Default:

 

(1) there is a default in the payment
of any principal of, or premium, if any, on, the Securities when the same becomes due and payable at Maturity, upon acceleration,
redemption or otherwise;

 

(2) there is a default in the payment
of any interest on any Security of a Series when the same becomes due and payable, and the Default continues for a period
of 30 days;

 

(3) the Company defaults in the observance
or performance of any other covenant in the Securities of a Series or in this Indenture for 90 days after written notice
from the Trustee or the Holders of not less than 25% in the aggregate principal amount of the Securities of such Series then
outstanding, which notice must specify the Default, demand that it be remedied and state that the notice is a “Notice of
Default”;

 

(4) the Company or any Significant Subsidiary
pursuant to or within the meaning of any Bankruptcy Law:

 

(A) commences a voluntary
case,

 

(B) consents to
the entry of an order for relief against it in an involuntary case,

 

(C) consents to the appointment
of a Custodian of it or for all or substantially all of its property,

 

(D) makes a general assignment
for the benefit of its creditors, or

 

(E) generally is not paying
its debts as they become due;

 

(5) a court of competent jurisdiction
enters an order or decree under any Bankruptcy Law that:

 

(A) is for relief against
the Company or any Significant Subsidiary in an involuntary case;

 

(B) appoints a Custodian
of the Company or any Significant Subsidiary, or for all or substantially all of the property of the Company or any Significant
Subsidiary; or

 

(C) orders the liquidation
of the Company or any Significant Subsidiary, and the order or decree remains unstayed and in effect for 90 consecutive days; or

 

(6) any other Event of Default provided
with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto or an Officers’
Certificate, in accordance with Section 2.2(19).

 

The term “Bankruptcy Law” means
Title 11, U.S. Code, or any similar federal or state law for the relief of debtors. The term “Custodian” means any
receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

 

The Trustee may withhold notice of any
Default (except in the payment of the principal of, or interest or premium, if any, on, the Securities) to the Holders of the Securities
of any Series in accordance with Section 7.5. When a Default is cured, it ceases to exist.

 

    17

     

    

 

6.2. ACCELERATION.

 

If an Event of Default with respect to
Securities of any Series at the time outstanding (other than an Event of Default arising under Section 6.1(4) or
(5)) occurs and is continuing, the Trustee by written notice to the Company, or the Holders of not less than 25% in aggregate
principal amount of the Securities of that Series then outstanding by written notice to the Company and the Trustee, may declare
that the entire principal amount of all the Securities of that Series then outstanding plus accrued and unpaid interest to
the date of acceleration are immediately due and payable, in which case such amounts shall become immediately due and payable;
PROVIDED, HOWEVER, that after such acceleration but before a judgment or decree based on such acceleration is obtained by the Trustee,
the Holders of a majority in aggregate principal amount of the outstanding Securities of that Series may rescind and annul
such acceleration and its consequences if (i) all existing Events of Default, other than the nonpayment of accelerated principal,
interest or premium, if any, that has become due solely because of the acceleration, have been cured or waived, (ii) to the
extent the payment of such interest is lawful, interest on overdue installments of interest and overdue principal, which has become
due otherwise than by such declaration of acceleration, has been paid and (iii) the rescission would not conflict with any
judgment or decree. No such rescission shall affect any subsequent Default or impair any right consequent thereto. In case an Event
of Default specified in Section 6.1(4) or (5) with respect to the Company occurs, such principal, premium, if any,
and interest amount with respect to all of the Securities of that Series shall be due and payable immediately without any
declaration or other act on the part of the Trustee or the Holders of the Securities of that Series.

 

6.3. REMEDIES.

 

If an Event of Default with respect to
Securities of any Series at the time outstanding occurs and is continuing, the Trustee may pursue any available remedy by
proceeding at law or in equity to collect the payment of the principal of, or interest and premium, if any, on, the Securities
of that Series, or to enforce the performance of any provision of the Securities of that Series or this Indenture.

 

The Trustee may maintain a proceeding even
if it does not possess any of the Securities of that Series or does not produce any of them in the proceeding. A delay or
omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair
the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy.
All available remedies are cumulative to the extent permitted by law.

 

6.4. WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT.

 

Subject to Sections 6.2, 6.7 and
8.2, the Holders of a majority in principal amount of the Securities of any Series then outstanding have the right to
waive any existing Default or Event of Default with respect to such Series or compliance with any provision of this
Indenture (with respect to such Series) or the Securities of such Series. Upon any such waiver, such Default with respect to
such Series shall cease to exist, and any Event of Default with respect to such Series arising therefrom shall be
deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other
Default or Event of Default or impair any right consequent thereto. This Section 6.4 shall be in lieu of TIA
Section 316(a)(1)(B), and TIA Section 316(a)(1)(B) is hereby expressly excluded from this Indenture and
Section as permitted by the TIA.

 

    18

     

    

 

6.5. CONTROL BY MAJORITY.

 

Subject to Sections 6.2, 6.7 and 8.2,
the Holders of a majority in principal amount of the Securities of any Series then outstanding may direct the time, method
and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the
Trustee by this Indenture with respect to such Series. The Trustee, however, may refuse to follow any direction that conflicts
with law or this Indenture, or that the Trustee determines may be unduly prejudicial to the rights of another Securityholder, or
that may involve the Trustee in personal liability; PROVIDED, that the Trustee may take any other action deemed proper by the Trustee
which is not inconsistent with such direction. This Section 6.5 shall be in lieu of TIA Section 316(a)(1)(A), and TIA
Section 316(a)(1)(A) is hereby expressly excluded from this Indenture and Section as permitted by the TIA.

 

6.6. LIMITATION ON SUITS.

 

Subject to Section 6.7, a Securityholder
may not institute any proceeding or pursue any remedy with respect to this Indenture or the Securities of a Series unless:

 

(1) the Holder gives to the Trustee written
notice of a continuing Event of Default with respect to the Securities of that Series;

 

(2) the Holders of at least 25% in aggregate
principal amount of the Securities of such Series then outstanding make a written request to the Trustee to pursue the remedy;

 

(3) such Holder or Holders offer to the
Trustee indemnity reasonably satisfactory to the Trustee against any loss, liability or expense to be incurred in compliance with
such request;

 

(4) the Trustee does not comply with the
request within 60 days after receipt of the request and the offer of indemnity; and

 

(5) no direction inconsistent with such
written request has been given to the Trustee during such 60-day period by the Holders of a majority in aggregate principal amount
of the Securities of such Series then outstanding.

 

A Securityholder may not use this Indenture
to prejudice the rights of another Securityholder, or to obtain a preference or priority over another Securityholder.

 

6.7. RIGHTS OF HOLDERS TO RECEIVE PAYMENT.

 

Notwithstanding any other provision of
this Indenture, the right of any Holder of a Security of a Series to receive payment of the principal of, and interest and
premium, if any, on, the Security of such Series on or after the respective due dates expressed in the Security of such Series,
or to bring suit for the enforcement of any such payment on or after such respective dates, is absolute and unconditional, and
shall not be impaired or affected without the consent of the Holder.

 

    19

     

    

 

6.8. COLLECTION SUIT BY TRUSTEE.

 

If an Event of Default in payment of principal,
interest or premium, if any, specified in Section 6.1(1) or (2) with respect to Securities of any Series at
the time outstanding occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust
against the Company (or any other obligor on the Securities of that Series) for the whole amount of unpaid principal and premium,
if any, and accrued interest remaining unpaid, together with interest on overdue principal and premium, if any, and, to the extent
that payment of such interest is lawful, interest on overdue installments of interest, in each case at the rate then borne by the
Securities of that Series, and such further amounts as shall be sufficient to cover the costs and expenses of collection, including
the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, as set forth in Section 7.7.

 

6.9. TRUSTEE MAY FILE PROOFS OF CLAIM.

 

The Trustee may file such proofs of
claim and other papers or documents, and take other actions (including sitting on a committee of creditors), as may be
necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel) and the Securityholders allowed in any judicial
proceedings relative to the Company (or any other obligor on the Securities), any of their respective creditors or any of
their respective property, and the Trustee shall be entitled and empowered to collect and receive any monies or other
property payable or deliverable on any such claims, and to distribute the same after deduction of its charges and expenses to
the extent that any such charges and expenses are not paid out of the estate in any such proceedings, and any custodian in
any such judicial proceeding is hereby authorized by each Securityholder to make such payments to the Trustee, and in the
event that the Trustee shall consent to the making of such payments directly to the Securityholders, to pay to the Trustee
any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel, and any other amounts due the Trustee under Section 7.7.

 

Nothing herein contained shall be deemed
to authorize the Trustee to authorize or consent to, or accept or adopt on behalf of any Securityholder, any plan of reorganization,
arrangement, adjustment or composition affecting the Securities of a Series or the rights of any Holder thereof, or to authorize
the Trustee to vote in respect of the claim of any Securityholder in any such proceedings.

 

6.10. PRIORITIES.

 

If the Trustee collects any money pursuant
to this Article 6, it shall pay out the money in the following order:

 

FIRST: to the Trustee for amounts
due under Section 7.7;

 

SECOND: to Securityholders for amounts
then due and unpaid for the principal of, and interest and premium, if any, on, the Securities in respect of which, or for the
benefit of which, such money has been collected, ratably, without preference or priority of any kind, according to the amounts
due and payable on such Securities; for principal and any premium and interest, respectively; and

 

THIRD: to the Company.

 

    20

     

    

 

 

The Trustee may fix a record date and payment
date for any payment to Securityholders pursuant to this Section 6.10. At least 15 days before such record date, the
Trustee shall mail to each Securityholder a notice that states the record date, the payment date and amount to be paid.

 

6.11. UNDERTAKING FOR COSTS.

 

In any suit for the enforcement of any
right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court
in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and
the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant
in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11
does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.7 or a suit by Holders of more than 10%
in principal amount of the Securities of a Series then outstanding.

 

ARTICLE 7 –

TRUSTEE

7.1. DUTIES OF TRUSTEE.

 

(a) If an Event of Default has occurred
and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture and use the same degree
of care and skill in their exercise as a prudent Person would exercise or use under the same circumstances in the conduct of his
own affairs.

 

(b) Except during the continuance of an
Event of Default:

 

(1) The Trustee need perform only those
duties that are specifically set forth in this Indenture, and no covenants or obligations shall be implied in this Indenture against
the Trustee.

 

(2) In the absence of bad faith on its
part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein,
upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture, but, in the case of
any such certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee
shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture.

 

(c) The Trustee may not be relieved from
liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that:

 

(1) This paragraph does not limit the
effect of paragraph (b) of this Section 7.1.

 

(2) The Trustee shall not be liable for
any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining
the pertinent facts.

 

(3) The Trustee shall not be liable with
respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Sections 6.2
and 6.5.

 

(d) No provision of this Indenture shall
require the Trustee to expend or risk its own funds, or otherwise incur any financial liability, in the performance of any of its
rights or powers if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity satisfactory
to it against such risk or liability is not reasonably assured to it.

 

(e) Whether or not therein expressly so
provided, paragraphs (a), (b), (c) and (d) of this Section 7.1 shall govern every provision of this Indenture that
in any way relates to the Trustee.

 

(f) The Trustee and Paying Agent shall
not be liable for interest on any money received by either of them, except as the Trustee and Paying Agent may agree in writing
with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by the
law.

 

(g) The Paying Agent, the Registrar and
any authenticating agent shall be entitled to the protections, immunities and standard of care set forth in paragraphs (a), (b),
(c), (d) and (f) of this Section 7.1 and in Section 7.2 with respect to the Trustee.

 

    21

     

    

 

7.2. RIGHTS OF TRUSTEE.

 

(a) Subject to Section 7.1:

 

(1) The Trustee may rely on, and shall
be protected in acting or refraining from acting upon, any document reasonably believed by it to be genuine and to have been signed
or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document.

 

(2) Before the Trustee acts or refrains
from acting, it may require an Officers’ Certificate or an Opinion of Counsel, or both, which shall conform to the provisions
of Section 10.5. The Trustee shall be protected and shall not be liable for any action it takes or omits to take in good faith
in reliance on such certificate or opinion.

 

(3) The Trustee may act through agents
and attorneys, and shall not be responsible for the misconduct or negligence of any agent appointed by it with due care.

 

(4) The Trustee shall not be liable for
any action it takes or omits to take in good faith which it reasonably believes to be authorized or within its rights or powers.

 

(5) The Trustee may consult with counsel
reasonably acceptable to the Trustee, which may be counsel to the Company, and the advice or opinion of such counsel as to matters
of law shall be full and complete authorization and protection from liability in respect of any action taken, omitted or suffered
by it hereunder in good faith and in accordance with the advice or opinion of such counsel.

 

(6) The Trustee shall be under no obligation
to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Holders
pursuant to the provisions of this Indenture, unless such Holders shall have offered to the Trustee reasonable security or indemnity
against the costs, expenses and liabilities which may be incurred therein or thereby.

 

(7) The Trustee shall not be deemed to
have knowledge of any fact or matter (including, without limitation, a Default or Event of Default) unless such fact or matter
is known to a Responsible Officer of the Trustee.

 

(8) Unless otherwise expressly provided
herein or in the Securities of a Series or the related Board Resolution, supplemental indenture or Officers’ Certificate,
the Trustee shall not have any responsibility with respect to reports, notices, certificates or other documents filed with it hereunder,
except to make them available for inspection, at reasonable times, by Securityholders, it being understood that delivery of such
reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall
not constitute constructive notice of any information contained therein or determinable from information contained therein, including
the Company’s compliance with any of its covenants hereunder (except as set forth in Section 4.4).

 

7.3. INDIVIDUAL RIGHTS OF TRUSTEE.

 

The Trustee in its individual or any
other capacity may become the owner or pledgee of Securities, and may make loans to, accept deposits from, perform services
for or otherwise deal with the Company, or any Affiliate thereof, with the same rights it would have if it were not Trustee.
Any Agent may do the same with like rights. The Trustee, however, shall be subject to Sections 7.10 and 7.11.

 

7.4. TRUSTEE’S DISCLAIMER.

 

The Trustee makes no representation as
to the validity or adequacy of this Indenture or the Securities (except that the Trustee represents that it is duly authorized
to execute and deliver this Indenture and authenticate the Securities and perform its obligations hereunder), and the Trustee shall
not be accountable for the Company’s use of the proceeds from the sale of Securities or any money paid to the Company pursuant
to the terms of this Indenture, and the Trustee shall not be responsible for any statement in the Securities other than its certificates
of authentication.

 

7.5. NOTICE OF DEFAULT.

 

If a Default or an Event of Default occurs
and is continuing with respect to the Securities of any Series, and if it is known to the Trustee, the Trustee shall mail to each
Securityholder of the Securities of that Series notice of the Default or the Event of Default, as the case may be, within
90 days after it occurs or, if later, after a Responsible Officer of the Trustee has knowledge of such Default or Event of
Default (except if such Default or Event of Default has been validly cured or waived before the giving of such notice). Except
in the case of a Default or an Event of Default in payment of the principal of, or interest or premium, if any, on, any Security
of any Series, the Trustee may withhold the notice if and so long as the Board of Directors of the Trustee, the executive committee
or any trust committee of such board and/or its Responsible Officers in good faith determine(s) that withholding the notice
is in the interests of the Securityholders of that Series.

 

    22

     

    

 

7.6. REPORTS BY TRUSTEE TO HOLDERS.

 

If and to the extent required by the TIA,
within 60 days after April 1 of each year, commencing the April 1 following the date of this Indenture, the Trustee
shall mail to each Securityholder a brief report dated as of such April 1 that complies with TIA Section 313(a). The
Trustee also shall comply with TIA Sections 313(b) and 313(c).

 

A copy of each report at the time of its
mailing to Securityholders shall be filed with the SEC and any stock exchange on which the Securities of that Series are listed.
The Company shall promptly notify the Trustee when the Securities of any Series are listed on any stock exchange or any delisting
thereof, and the Trustee shall comply with TIA Section 313(d).

 

7.7. COMPENSATION AND INDEMNITY.

 

The Company shall pay to the Trustee from
time to time reasonable compensation for its services. The Trustee’s compensation shall not be limited by any provision of
law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee within 45 days after receipt
of request for all reasonable out-of-pocket disbursements and expenses incurred or made by it in connection with its duties under
this Indenture, including the reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel.

 

The Company shall indemnify the Trustee
for, and hold it harmless against, any and all loss or liability incurred by it in connection with the acceptance or performance
of its duties under this Indenture including the reasonable costs and expenses of defending itself against any claim or liability
in connection with the exercise or performance of any of its powers or duties hereunder. The Trustee shall notify the Company promptly
of any claim asserted against the Trustee for which it may seek indemnity.

 

The failure by the Trustee to so notify
the Company shall not however relieve the Company of its obligations. Notwithstanding the foregoing, the Company need not reimburse
the Trustee for any expense or indemnify it against any loss or liability incurred by the Trustee through its negligence or bad
faith. To secure the payment obligations of the Company in this Section 7.7, the Trustee shall have a lien prior to the Securities
of any Series on all money or property held or collected by the Trustee except such money or property held in trust to pay
the principal of, interest and premium, if any, on particular Securities of that Series.

 

When the Trustee incurs expenses or renders
services after an Event of Default specified in Section 6.1(4) or (5) occurs, the expenses and the compensation
for the services are intended to constitute expenses of administration under any Bankruptcy Law.

 

For purposes of this Section 7.7,
the term “Trustee” shall include any trustee appointed pursuant to this Article 7.

 

7.8. REPLACEMENT OF TRUSTEE.

 

The Trustee may resign with respect to
the Securities of one or more Series by so notifying the Company in writing at least 90 days in advance of such resignation.

 

The Holders of a majority in principal
amount of the outstanding Securities of any Series may remove the Trustee with respect to that Series by notifying the
removed Trustee in writing and may appoint a successor Trustee with respect to that Series with the consent of the Company,
which consent shall not be unreasonably withheld. The Company may remove the Trustee with respect to that Series at its election
if:

 

(1) the Trustee fails to comply with,
or ceases to be eligible under, Section 7.10;

 

(2) the Trustee is adjudged a bankrupt
or an insolvent, or an order for relief is entered with respect to the Trustee, under any Bankruptcy Law;

 

(3) a Custodian or other public officer
takes charge of the Trustee or its property; or

 

(4) the Trustee otherwise becomes incapable
of acting.

 

(5) If the Trustee resigns or is removed,
or if a vacancy exists in the office of Trustee, with respect to any Series of Securities for any reason, the Company shall
promptly appoint, by Board Resolution, a successor Trustee.

 

If a successor Trustee with respect to
the Securities of one or more Series does not take office within 60 days after the retiring Trustee resigns or is removed,
the retiring Trustee, the Company or the Holders of at least 10% in principal amount of the outstanding Securities of the applicable
Series may petition any court of competent jurisdiction for the appointment of a successor Trustee.

 

If the Trustee with respect to the Securities
of one or more Series fails to comply with Section 7.10, any Securityholder of the applicable Series may petition
any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

 

    23

     

    

 

A successor Trustee shall deliver a written
acceptance of its appointment to the retiring Trustee and to the Company. Immediately following such delivery, (i) the retiring
Trustee with respect to one or more Series shall, subject to its rights under Section 7.7, transfer all property held
by it as Trustee with respect to such Series to the successor Trustee, (ii) the resignation or removal of the retiring
Trustee shall become effective and (iii) the successor Trustee with respect to such Series shall have all the rights,
powers and duties of the Trustee under this Indenture. A successor Trustee with respect to the Securities of one or more Series shall
mail notice of its succession to each Securityholder of such Series.

 

7.9. SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION.

 

If the Trustee, or any Agent, consolidates
with, merges or converts into, or transfers all or substantially all of its corporate trust assets to, another corporation, subject
to Section 7.10, the successor corporation without any further act shall be the successor Trustee or Agent, as the case may
be.

 

7.10. ELIGIBILITY; DISQUALIFICATION.

 

This Indenture shall always have a Trustee
who satisfies the requirements of TIA Sections 310(a)(1), (2) and (5) in every respect. The Trustee (or in the case of
a Trustee that is a Person included in a bank holding company system, the related bank holding company) shall have a combined capital
and surplus of at least $100,000,000 as set forth in its most recent published annual report of condition. The Trustee shall comply
with TIA Section 310(b), including the provision in Section 310(b)(1). In addition, if the Trustee is a Person included
in a bank holding company system, the Trustee, independently of such bank holding company, shall meet the capital requirements
of TIA Section 310(a)(2). If at any time the Trustee shall cease to be eligible in accordance with the provisions of this
Section 7.10, it shall resign immediately in the manner and with the effect specified in this Article 7.

 

7.11. PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY.

 

The Trustee shall comply with TIA Section 311(a),
excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed shall be subject
to TIA Section 311(a) to the extent indicated therein.

 

7.12. PAYING AGENTS.

 

The Company shall cause each Paying Agent
other than the Trustee to execute and deliver to it and the Trustee an instrument in which such agent shall agree with the Trustee,
subject to the provisions of this Section 7.12:

 

(1) that it will hold all sums held by
it as agent for the payment of the principal of, or interest or premium, if any, on, the Securities (whether such sums have been
paid to it by the Company or by any obligor on the Securities) in trust for the benefit of Holders of the Securities or the Trustee;

 

(2) that it will at any time during the
continuance of any Event of Default, upon written request from the Trustee, deliver to the Trustee all sums so held in trust by
it together with a full accounting thereof; and

 

(3) that it will give the Trustee written
notice within three Business Days after any failure of the Company (or by any obligor on the Securities) in the payment of any
installment of the principal of, or interest or premium, if any, on, the Securities when the same shall be due and payable.

 

ARTICLE 8 –

AMENDMENTS, SUPPLEMENTS AND WAIVERS

 

8.1. WITHOUT CONSENT OF HOLDERS.

 

The Company, when authorized by a Board
Resolution, and the Trustee may amend, restate or supplement this Indenture or the Securities of one or more Series without
notice to or consent of any Securityholder:

 

(1) to comply with Section 5.1;

 

(2) to provide for certificated Securities
in addition to uncertificated Securities;

 

(3) to comply with any requirements of
the SEC under the TIA;

 

(4) to cure any ambiguity, defect or inconsistency,
or to make any other change herein or in the Securities that does not materially and adversely affect the rights of any Securityholder;

 

(5) to provide for the issuance of, and
establish the form and terms and conditions of, Securities of any Series as permitted by this Indenture; or

 

(6) to evidence and provide for the acceptance
of appointment hereunder by a successor Trustee with respect to the Securities of one or more Series, and to add to or change any
of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder
by more than one Trustee.

 

    24

     

    

 

The Trustee is hereby authorized to join
with the Company in the execution of any supplemental indenture authorized or permitted by the terms of this Indenture, and to
make any further appropriate agreements and stipulations which may be therein contained, but the Trustee shall not be obligated
to enter into any such supplemental indenture which adversely affects its own rights, duties or immunities under this Indenture.

 

8.2. WITH CONSENT OF HOLDERS.

 

(a) The Company, when authorized by a Board
Resolution, and the Trustee may amend, restate or supplement this Indenture or the Securities of one or more Series with the
written consent of the Holders of not less than a majority in aggregate principal amount of the outstanding Securities of such
Series affected by such amendment, restatement or supplement without notice to any Securityholder. The Holders of not less
than a majority in aggregate principal amount of the outstanding Securities of each such Series affected by such amendment,
restatement or supplement may waive compliance by the Company in a particular instance with any provision of this Indenture or
the Securities of such Series without notice to any Securityholder. Subject to Section 8.4, without the consent of each
Securityholder affected, however, an amendment, supplement or waiver may not:

 

(1) reduce the amount of Securities whose
Holders must consent to an amendment, supplement or waiver to this Indenture or the Securities;

 

(2) reduce the rate of, or change the
time for payment of, interest on any Security;

 

(3) reduce the principal, or change the
Stated Maturity, of any Security, or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous
obligation;

 

(4) make any Security payable in a currency
other than that stated in the Security;

 

(5) change the amount or time of any payment
required by the Securities, or reduce the premium payable upon any redemption of the Securities, or change the time before which
no such redemption may be made;

 

(6) waive a Default or Event of Default
in the payment of the principal of, or interest or premium, if any, on, any Security (except a rescission of acceleration of the
Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series and
a waiver of the payment default that resulted from such acceleration);

 

(7) waive a redemption payment with respect
to any Security, or change any of the provisions with respect to the redemption of any Securities;

 

(8) make any changes in Section 6.6
or this Section 8.2, except to increase any percentage of Securities the Holders of which must consent to any matter; or

 

(9) take any other action otherwise prohibited
by this Indenture to be taken without the consent of each Holder affected thereby.

 

(b) Upon the request of the Company, accompanied
by a Board Resolution authorizing the execution of any such supplemental indenture, and upon the receipt by the Trustee of evidence
reasonably satisfactory to the Trustee of the consent of the Securityholders as aforesaid and of the documents described in Section 8.6,
the Trustee shall join with the Company in the execution of such supplemental indenture, unless such supplemental indenture affects
the Trustee’s own rights, duties or immunities under this Indenture, in which case the Trustee may in its discretion, but
shall not be obligated to, enter into such supplemental indenture.

 

(c) It shall not be necessary for the consent
of the Holders under this section to approve the particular form of any proposed amendment, restatement, supplement or waiver,
but it shall be sufficient if such consent approves the substance thereof.

 

After an amendment, restatement or supplement
under this Section becomes effective, the Company shall mail to Securityholders a notice briefly describing the amendment,
restatement or supplement. Any failure of the Company to mail any such notice, or any defect therein, shall not, however, in any
way impair or affect the validity of any supplemental indenture.

 

8.3. COMPLIANCE WITH TRUST INDENTURE ACT.

 

Every amendment to, or supplement of, this
Indenture or the Securities shall comply with the TIA as then in effect.

 

    25

     

    

 

8.4. REVOCATION AND EFFECT OF CONSENTS.

 

Until an amendment, restatement, supplement,
waiver or other action becomes effective, a consent to it by a Holder of a Security is a continuing consent conclusive and binding
upon such Holder and every subsequent Holder of the same Security or portion thereof, and of any Security issued upon the transfer
thereof or in exchange therefor or in place thereof, even if notation of the consent is not made on any such Security. Any such
Holder or subsequent Holder, however, may revoke the consent as to his Security or portion of a Security, if the Trustee receives
the notice of revocation before the date the amendment, restatement, supplement, waiver or other action becomes effective.

 

The Company may, but shall not be obligated
to, fix a record date for the purpose of determining the Holders entitled to consent to any amendment, restatement, supplement
or waiver, which record date shall be at least 30 days prior to the first solicitation of such consent. If a record date is
fixed, then, notwithstanding the preceding paragraph, those Persons who were Holders at such record date (or their duly designated
proxies), and only such Persons, shall be entitled to consent to such amendment, restatement, supplement or waiver, or to revoke
any consent previously given, whether or not such Persons continue to be Holders after such record date.

 

After an amendment, restatement, supplement,
waiver or other action becomes effective, it shall bind every Securityholder, unless it makes a change described in any of clauses
(1) through (9) of Section 8.2. In that case, the amendment, restatement, supplement, waiver or other action shall
bind each Holder of a Security who has consented to it and every subsequent Holder of a Security or portion of a Security that
evidences the same debt as the consenting Holder’s Security; PROVIDED, that any such waiver shall not impair or affect the
right of any Holder to receive payment of the principal of, and interest and premium, if any, on, a Security, on or after the respective
due dates expressed in such Security, or to bring suit for the enforcement of any such payment on or after such respective dates
without the consent of such Holder.

 

8.5. NOTATION ON OR EXCHANGE OF SECURITIES.

 

If an amendment, restatement, supplement
or waiver changes the terms of a Security of any Series, the Trustee may request the Holder of such Security to deliver it to the
Trustee. In such case, the Trustee shall place an appropriate notation on such Security about the changed terms and return it to
the Holder. Alternatively, the Company, in exchange for such Security, may issue, and the Trustee shall authenticate, a new security
that reflects the changed terms. Failure to make the appropriate notation or issue a new Security shall not affect the validity
and effect of such amendment, restatement, supplement or waiver.

 

8.6. TRUSTEE TO SIGN AMENDMENTS, ETC.

 

The Trustee shall sign any amendment, restatement,
supplement or waiver authorized pursuant to this Article 8 if the amendment, restatement, supplement or waiver does not adversely
affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may, but need not, sign it. In signing
or refusing to sign such amendment, restatement, supplement or waiver the Trustee shall be entitled to receive and, subject to
Section 7.1, shall be fully protected in relying upon an Officers’ Certificate and an Opinion of Counsel stating that
such amendment, restatement, supplement or waiver is authorized or permitted by this Indenture. The Company may not sign an amendment,
restatement or supplement until the Board of Directors of the Company approves it.

 

ARTICLE 9 –

DISCHARGE OF INDENTURE; DEFEASANCE

 

9.1. DISCHARGE OF INDENTURE.

 

The Company may terminate its obligations
under the Securities of any Series and this Indenture with respect to such Series, except the obligations referred to in the
last paragraph of this Section 9.1, if there shall have been canceled by the Trustee, or delivered to the Trustee for cancellation,
all Securities of such Series theretofore authenticated and delivered (other than any Securities of such Series that
are asserted to have been destroyed, lost or stolen and that shall have been replaced as provided in Section 2.8) and the
Company has paid all sums payable by it hereunder or deposited all required sums with the Trustee.

 

After such delivery the Trustee upon request
shall acknowledge in a writing prepared by or on behalf of the Company the discharge of the Company’s obligations under the
Securities of such Series and this Indenture, except for those surviving obligations specified below.

 

Notwithstanding the satisfaction and discharge
of this Indenture, the obligations of the Company in Sections 7.7, 9.5 and 9.6 shall survive.

 

    26

     

    

 

9.2. LEGAL DEFEASANCE.

 

The Company may at its option, by Board
Resolution, be discharged from its obligations with respect to the Securities of any Series on the date upon which the conditions
set forth in Section 9.4 below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, such Legal Defeasance
means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by the Securities of such
Series and to have satisfied all its other obligations under such Securities and this Indenture insofar as such Securities
are concerned (and the Trustee, at the expense of the Company, shall, subject to Section 9.6, execute proper instruments acknowledging
the same, as are delivered to it by the Company), except for the following, which shall survive until otherwise terminated or discharged
hereunder: (A) the rights of Holders of outstanding Securities of such Series to receive solely from the trust funds
described in Section 9.4 and as more fully set forth in such section, payments in respect of the principal of, and interest
and premium, if any, on, the Securities of such Series when such payments are due, (B) the Company’s obligations
with respect to the Securities of such Series under Sections 2.4, 2.5, 2.6, 2.7, 2.8 and 2.9, (C) the rights, powers,
trusts, duties and immunities of the Trustee hereunder (including claims of, or payments to, the Trustee under or pursuant to Section 7.7)
and (D) this Article 9. Subject to compliance with this Article 9, the Company may exercise its option under this
Section 9.2 with respect to the Securities of any Series notwithstanding the prior exercise of its option under Section 9.3
below with respect to the Securities of such Series.

 

9.3. COVENANT DEFEASANCE.

 

At the option of the Company, pursuant
to a Board Resolution, the Company shall be released from its obligations with respect to the outstanding Securities of any Series under
Sections 4.2 through 4.5, inclusive, and Section 5.1, with respect to the outstanding Securities of such Series, on and
after the date the conditions set forth in Section 9.4 are satisfied (hereinafter, “Covenant Defeasance”). For
this purpose, such Covenant Defeasance means that the Company may omit to comply with and shall have no liability in respect of
any term, condition or limitation set forth in any such specified section or portion thereof, whether directly or indirectly by
reason of any reference elsewhere herein to any such specified Section or portion thereof or by reason of any reference in
any such specified section or portion thereof to any other provision herein or in any other document, but the remainder of this
Indenture and the Securities of any Series shall be unaffected thereby.

 

9.4. CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE.

 

The following shall be the conditions to
application of Section 9.2 or Section 9.3 to the outstanding Securities of a Series:

 

(1) the Company shall irrevocably have
deposited or caused to be deposited with the Trustee (or another trustee satisfying the requirements of Section 7.10 who shall
agree to comply with the provisions of this Article 9 applicable to it) as funds in trust for the purpose of making the following
payments, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities, (A) money
in an amount, or (B) U.S. Government Obligations or Foreign Government Obligations which through the scheduled payment of
principal and interest in respect thereof in accordance with their terms will provide, not later than the due date of any payment,
money in an amount, or (C) a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent
public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge, and which shall
be applied by the Trustee (or other qualifying trustee) to pay and discharge, the principal of, and accrued interest and premium,
if any, on, the outstanding Securities of such Series at the Stated Maturity of such principal, interest or premium, if any,
or on dates for payment and redemption of such principal, interest and premium, if any, selected in accordance with the terms of
this Indenture and of the Securities of such Series;

 

(2) no Event of Default or Default with
respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit, or shall have
occurred and be continuing at any time during the period ending on the 91st day after the date of such deposit or, if longer, ending
on the day following the expiration of the longest preference period under any Bankruptcy Law applicable to the Company in respect
of such deposit as specified in the Opinion of Counsel identified in paragraph (8) below (it being understood that this condition
shall not be deemed satisfied until the expiration of such period);

 

(3) such Legal Defeasance or Covenant
Defeasance shall not cause the Trustee to have a conflicting interest for purposes of the TIA with respect to any securities of
the Company;

 

(4) such Legal Defeasance or Covenant
Defeasance shall not result in a breach or violation of, or constitute default under, any other agreement or instrument to which
the Company is a party or by which it is bound;

 

(5) the Company shall have delivered to
the Trustee an Opinion of Counsel stating that, as a result of such Legal Defeasance or Covenant Defeasance, neither the trust
nor the Trustee will be required to register as an investment company under the Investment Company Act of 1940, as amended;

 

(6) in the case of an election under Section 9.2,
the Company shall have delivered to the Trustee an Opinion of Counsel stating that (i) the Company has received from, or there
has been published by, the Internal Revenue Service a ruling to the effect that or (ii) there has been a change in any applicable
Federal income tax law with the effect that, and such opinion shall confirm that, the Holders of the outstanding Securities of
such Series or Persons in their positions will not recognize income, gain or loss for Federal income tax purposes solely as
a result of such Legal Defeasance and will be subject to Federal income tax on the same amounts, in the same manner, including
as a result of prepayment, and at the same times as would have been the case if such Legal Defeasance had not occurred;

 

    27

     

    

 

(7) in the case of an election under Section 9.3,
the Company shall have delivered to the Trustee an Opinion of Counsel to the effect that the Holders of the outstanding Securities
of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such Covenant Defeasance,
and will be subject to Federal income tax on the same amounts, in the same manner and at the same times as would have been the
case if such Covenant Defeasance had not occurred;

 

(8) the Company shall have delivered to
the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent provided for in
this Article 9 relating to either the Legal Defeasance under Section 9.2 or the Covenant Defeasance under Section 9.3
(as the case may be) have been complied with;

 

(9) the Company shall have delivered to
the Trustee an Officers’ Certificate stating that the deposit under clause (1) was not made by the Company with the
intent of defeating, hindering, delaying or defrauding any creditors of the Company or others; and

 

(10) the Company shall have paid, or duly
provided for payment under terms mutually satisfactory to the Company and the Trustee, all amounts then due to the Trustee pursuant
to Section 7.7.

 

9.5. DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT
OBLIGATIONS TO BE HELD IN TRUST; OTHER MISCELLANEOUS PROVISIONS.

 

All money, U.S. Government Obligations
and Foreign Government Obligations (including the proceeds thereof) deposited with the Trustee pursuant to Section 9.4 in
respect of the outstanding Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such
Securities and this Indenture, to the payment, either directly or through any Paying Agent as the Trustee may determine, to the
Holders of such Securities, of all sums due and to become due thereon in respect of principal, accrued interest and premium, if
any, but such money need not be segregated from other funds except to the extent required by law.

 

The Company shall pay and indemnify
the Trustee against any tax, fee or other charge imposed on or assessed against the U.S. Government Obligations and Foreign
Government Obligations deposited pursuant to Section 9.4 or the principal, interest and premium, if any, received in
respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the
outstanding Securities.

 

Anything in this Article 9 to the
contrary notwithstanding, but subject to payment of any of its outstanding fees and expenses, the Trustee shall deliver or pay
to the Company from time to time upon Company Request any money, U.S. Government Obligations or Foreign Government Obligations
held by the Trustee as provided in Section 9.4 which, in the opinion of a nationally-recognized firm of independent public
accountants expressed in a written certification thereof delivered to the Trustee, are in excess of the amount thereof which would
then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance.

 

9.6. REINSTATEMENT.

 

If the Trustee or Paying Agent is unable
to apply any money, U.S. Government Obligations or Foreign Government Obligations in accordance with Section 9.1, 9.2, 9.3
or 9.4 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining,
restraining or otherwise prohibiting such application, the Company’s obligations under this Indenture and the Securities
shall be revived and reinstated as though no deposit had occurred pursuant to this Article 9 until such time as the Trustee
or Paying Agent is permitted to apply all such money, U.S. Government Obligations or Foreign Government Obligations, as the case
may be, in accordance with Section 9.1, 9.2, 9.3 or 9.4; PROVIDED, HOWEVER, that if the Company has made any payment of principal
of, or accrued interest or premium, if any, on, any Securities because of the reinstatement of its obligations, the Company shall
be subrogated to the rights of the Holders of such Securities to receive such payment from the money, U.S. Government Obligations
or Foreign Government Obligations held by the Trustee or Paying Agent.

 

9.7. MONEYS HELD BY PAYING AGENT.

 

In connection with the satisfaction and
discharge of this Indenture, all moneys then held by any Paying Agent under the provisions of this Indenture shall, upon demand
of the Company, be paid to the Trustee, or, if sufficient moneys have been deposited pursuant to Section 9.1, be paid to the
Company, and thereupon such Paying Agent shall be released from all further liability with respect to such moneys.

 

    28

     

    

 

9.8. MONEYS HELD BY TRUSTEE.

 

Any moneys deposited with the Trustee or
any Paying Agent or then held by the Company in trust for the payment of the principal of, or interest or premium, if any, on,
any Security that are not applied but remain unclaimed by the Holder of such Security for two years after the date upon which the
principal of, or interest or premium, if any, on, such Security shall have respectively become due and payable shall be repaid
to the Company upon Company Request, or if such moneys are then held by the Company in trust, such moneys shall be released from
such trust; and the Holder of such Security entitled to receive such payment shall thereafter, as an unsecured general creditor,
look only to the Company for the payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust
money shall thereupon cease. After payment to the Company or the release of any money held in trust by the Company, Securityholders
entitled to the money must look only to the Company for payment as general creditors, unless applicable abandoned property law
designates another Person.

 

ARTICLE 10 –

MISCELLANEOUS

 

10.1. TRUST INDENTURE ACT CONTROLS.

 

If any provision of this Indenture limits,
qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the required TIA provision
shall control. If any provision of this Indenture modifies or excludes any provision of the TIA which may be so modified or excluded,
the latter provision shall be deemed to apply to this Indenture as so modified or to be excluded, as the case may be.

 

10.2. NOTICES.

 

Any notice or communication shall be given
in writing and delivered in Person, sent by facsimile (and receipt confirmed by telephone or electronic transmission report), delivered
by commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows:

 

If to the Company:

 

Passage Bio, Inc.

Two Commerce Square

2001 Market Street, 28th Floor

Philadelphia, PA 19103

Attention: Chief Financial Officer

 

Copy to:

 

Fenwick & West LLP

555 California Street

San Francisco, CA, 94104

Fax: (650) 988-5200

Attention: Robert Freedman

 

If to the Trustee:

 

The Company or the Trustee by written notice
to the other may designate additional or different addresses for subsequent notices or communications. Any notice or communication
to the Company or the Trustee shall be deemed to have been given or made as of the date so delivered if personally delivered; when
receipt is confirmed by telephone or electronic transmission report, if sent by facsimile; and three Business Days after mailing
if sent by registered or certified mail, postage prepaid (except that a notice of change of address shall not be deemed to have
been given until actually received by the addressee).

 

Any notice or communication mailed to a
Securityholder shall be mailed to such Securityholder by first-class mail, postage prepaid, at such Securityholder’s address
shown on the register kept by the Registrar.

 

Failure to mail, or any defect in, a notice
or communication to a Securityholder shall not affect its sufficiency with respect to other Securityholders. If a notice or communication
to a Securityholder is mailed in the manner provided above, it shall be deemed duly given, three Business Days after such mailing,
whether or not the addressee receives it.

 

In case by reason of the suspension of
regular mail service, or by reason of any other cause, it shall be impossible to mail any notice as required by this Indenture,
then such method of notification as shall be made with the approval of the Trustee shall constitute a sufficient mailing of such
notice.

 

In the case of Global Securities, notices
or communications to be given to Securityholders shall be given to the Depository, in accordance with its applicable policies as
in effect from time to time.

 

In addition to the manner provided for
in the foregoing provisions, notices or communications to Securityholders may be given by the Company by release made to Reuters
Economic Services and Bloomberg Business News.

 

    29

     

    

 

10.3. COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS.

 

Securityholders of any Series may
communicate pursuant to TIA Section 312(b) with other Securityholders of that Series or any other Series with
respect to their rights under this Indenture or the Securities of that Series or any other Series. The Company, the Trustee,
the Registrar and any other Person shall have the protection of TIA Section 312(c).

 

10.4. CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT.

 

Upon any request or application by the
Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:

 

(1) an Officers’ Certificate (which
shall include the statements set forth in Section 10.5 below) stating that, in the opinion of the signers, all conditions
precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and

 

(2) an Opinion of Counsel (which shall
include the statements set forth in Section 10.5 below) stating that, in the opinion of such counsel, all such conditions
precedent have been complied with.

 

10.5. STATEMENT REQUIRED IN CERTIFICATE AND OPINION.

 

Each certificate and opinion with respect
to compliance with a condition or covenant provided for in this Indenture (other than pursuant to Section 4.4) shall include:

 

(1) a statement that the Person making
such certificate or opinion has read such covenant or condition;

 

(2) a brief statement as to the nature
and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are
based;

 

(3) a statement that, in the opinion of
such Person, it or he has made such examination or investigation as is necessary to enable it or him to express an informed opinion
as to whether or not such covenant or condition has been complied with; and

 

(4) a statement as to whether or not,
in the opinion of such Person, such covenant or condition has been complied with.

 

10.6. RULES BY TRUSTEE AND AGENTS.

 

The Trustee may make reasonable rules for
action by or at meetings of Securityholders. The Registrar, Paying Agent and Service Agent may make reasonable rules for their
functions.

 

10.7. BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT.

 

A “Business Day” is a day that
is not a Legal Holiday. A “Legal Holiday” is a Saturday, a Sunday, a federally-recognized holiday or a day on which
banking institutions are not authorized or required by law, regulation or executive order to be open in the State of New York.

 

If a payment date is a Legal Holiday at
a Place of Payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall
accrue for the intervening period. “Place of Payment” means the place or places where the principal of, and interest
and premium, if any, on, the Securities of a Series are payable as specified as contemplated by Section 2.2. If the regular
record date is a Legal Holiday, the record date shall not be affected.

 

10.8. GOVERNING LAW.

 

THIS INDENTURE AND THE SECURITIES SHALL
BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED WITHIN
THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.

 

10.9. NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS.

 

This Indenture may not be used to interpret
another indenture, loan, security or debt agreement of the Company or any Subsidiary thereof. No such indenture, loan, security
or debt agreement may be used to interpret this Indenture.

 

    30

     

    

 

10.10. NO RECOURSE AGAINST OTHERS.

 

A director, officer, employee, stockholder
or incorporator, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or
the Indenture. Each Securityholder by accepting a Security waives and releases all such liability. Such waiver and release are
part of the consideration for the issuance of the Securities.

 

10.11. SUCCESSORS.

 

All covenants and agreements of the Company
in this Indenture and the Securities shall bind the Company’s successors and assigns, whether so expressed or not. All agreements
of the Trustee, any additional trustee and any Paying Agents in this Indenture shall bind their respective successors and assigns.

 

10.12. MULTIPLE COUNTERPARTS.

 

The parties may sign multiple counterparts
(which may include counterparts delivered by any standard form of telecommunication) of this Indenture. Each signed counterpart
shall be deemed an original, but all of them together represent one and the same agreement. Counterparts may be delivered via facsimile,
electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions
Act, the Electronics Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and
any counterparty so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

10.13. TABLE OF CONTENTS, HEADINGS, ETC.

 

The table of contents, cross-reference
sheet and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not
to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.

 

10.14. SEVERABILITY.

 

Each provision of this Indenture shall
be considered separable, and if for any reason any provision which is not essential to the effectuation of the basic purpose of
this Indenture or the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby, and a Holder shall have no claim therefor against any party hereto.

 

10.15. SECURITIES IN A FOREIGN CURRENCY OR IN EUROS.

 

Unless otherwise specified in a Board Resolution,
a supplemental indenture hereto or an Officers’ Certificate delivered pursuant to Section 2.2 with respect to a particular
Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage
in aggregate principal amount of Securities of all Series or all Series affected by a particular action at the time outstanding
and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars
(including Euros), then the principal amount of Securities of such Series which shall be deemed to be outstanding for the
purpose of taking such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate
at such time. For purposes of this Section 10.15, “Market Exchange Rate” shall mean the noon Dollar buying rate
in New York City for cable transfers of that currency as published by the Federal Reserve Bank of New York; PROVIDED, HOWEVER,
in the case of Euros, Market Exchange Rate shall mean the rate of exchange determined by the Commission of the European Union (or
any successor thereto) as published in the Official Journal of the European Union (such publication or any successor publication,
the “Journal”). If such Market Exchange Rate is not available for any reason with respect to such currency, the Trustee
shall use, in its sole discretion and without liability on its part, such quotation of the Federal Reserve Bank of New York or,
in the case of Euros, the rate of exchange as published in the Journal, as of the most recent available date, or quotations or,
in the case of Euros, rates of exchange from one or more major banks in New York City or in the country of issue of the currency
in question or, in the case of Euros, in Luxembourg or such other quotations or, in the case of Euros, rates of exchange as the
Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this paragraph shall apply in determining
the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection
with any action taken by Holders of Securities pursuant to the terms of this Indenture.

 

All decisions and determinations of the
Trustee regarding the Market Exchange Rate or any alternative determination provided for in the preceding paragraph shall be in
the Trustee’s sole discretion, and shall, in the absence of manifest error, be conclusive to the extent permitted by law
for all purposes and irrevocably binding upon the Company and all Holders.

 

    31

     

    

 

10.16. JUDGMENT CURRENCY.

 

The Company agrees, to the fullest extent
that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is necessary
to convert the sum due in respect of the principal of, or interest or premium, if any, or other amount on, the Securities of any
Series (the “Required Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”),
the rate of exchange used shall be the rate at which, in accordance with normal banking procedures, the Trustee could purchase
in The City of New York the Required Currency with the Judgment Currency on the day on which final unappealable judgment is entered,
unless such day is not a Business Day, in which instance, the rate of exchange used shall be the rate at which, in accordance with
normal banking procedures, the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency
on the Business Day preceding the day on which final unappealable judgment is entered and (b) its obligations under this Indenture
to make payments in the Required Currency (i) shall not be discharged or satisfied by any tender or any recovery pursuant
to any judgment (whether or not entered in accordance with subsection (a)) in any currency other than the Required Currency, except
to the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required
Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause
of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short
of the full amount of the Required Currency so expressed to be payable and (iii) shall not be affected by judgment being obtained
for any other sum due under this Indenture.

 

[REMAINDER OF THIS PAGE INTENTIONALLY
LEFT BLANK]

 

    32

     

    

 

IN WITNESS WHEREOF, the parties hereto
have caused this Indenture to be duly executed, and their respective corporate seals to be hereunto affixed and attested, all as
of the day and year first above written.

 

	 	PASSAGE BIO, INC.
	 	 	 
	 	By:	 
	 	 	Name:	 
	 	 	Title:	 

 

	 	[Name of Trustee]
	 	 	 
	 	By:	 
	 	 	Name:	 
	 	 	Title:	 

 

	 	By:	 
	 	 	Name:	 
	 	 	Title:	 

 

    33Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT
(this “Subscription Agreement”) is entered into this [●] day of March, 2021, by and among Good Works Acquisition
Corp., a Delaware corporation (the “Issuer”), and the undersigned (“Subscriber”). Defined
terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Merger Agreement (as defined
below).

 

WHEREAS, the Issuer,
Cipher Mining Technologies, Inc., a Delaware corporation (the “Company”), and the other parties named therein
will concurrently with the execution of this Subscription Agreement, enter into that certain Agreement and Plan of Merger, dated
as of the date hereof (as amended, amended and restated, modified, supplemented, or waived from time to time in accordance with
its terms, the “Merger Agreement”), pursuant to which the Issuer, its merger subsidiary and the Company shall
enter into a business combination transaction, with the Company surviving as the surviving entity, on the terms and subject to
the conditions set forth therein (together with the other transactions contemplated by the Merger Agreement, the “Transactions”);

 

WHEREAS, in connection
with the Transactions, Subscriber desires to subscribe for and purchase from the Issuer that number of shares of the common stock
of the Issuer, par value $0.001 per share (the “Common Stock”), set forth on Subscriber’s signature page
hereto (the “Shares”) for a purchase price of $10.00 per share, for the aggregate purchase price set forth on
Subscriber’s signature page hereto (the “Purchase Price”), and the Issuer desires to issue and sell to
Subscriber the Shares in consideration of the payment of the Purchase Price therefor by or on behalf of Subscriber to the Issuer,
all on the terms and conditions set forth herein; and

 

WHEREAS, certain other
“qualified institutional buyers” (as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities
Act”)) or institutional “accredited investors” (within the meaning of Rule 501(a) of Regulation D under the
Securities Act) (each, an “Other Subscriber”) have, severally and not jointly, entered into separate subscription
agreements with the Issuer (the “Other Subscription Agreements”), pursuant to which such Other Subscribers have
agreed to purchase Common Stock on the Closing Date at the same per share purchase price as the Subscriber, and the aggregate amount
of securities to be sold by the Issuer pursuant to this Subscription Agreement and the Other Subscription Agreements equals, as
of the date hereof, [●] shares of Common Stock and the aggregate value of the consideration received by the Issuer in connection
with the purchase and sale of the Shares equals $[●].

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual representations, warranties, and covenants, and subject to the conditions, herein
contained, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

 

1. 
Subscription. Subject to the terms and conditions hereof, at the Closing, Subscriber hereby agrees to subscribe for
and purchase, and the Issuer hereby agrees to issue and sell to Subscriber, upon the payment of the Purchase Price, the Shares
(such subscription and issuance, the “Subscription”).

 

2. 
Representations, Warranties, and Agreements.

 

2.1 
Subscriber’s Representations, Warranties, and Agreements. To induce the Issuer to issue the Shares to Subscriber,
Subscriber hereby represents and warrants to the Issuer and acknowledges and agrees with the Issuer as follows:

 

2.1.1 
Subscriber has been duly formed or incorporated and is validly existing and in good standing under the laws of its jurisdiction
of incorporation or formation, with power and authority to enter into, deliver, and perform its obligations under this Subscription
Agreement.

 

     

     

    

 

2.1.2 
 This Subscription Agreement has been duly authorized, validly executed and delivered by Subscriber. Assuming that this
Subscription Agreement has been duly authorized, executed and delivered by the Issuer, this Subscription Agreement is the valid
and binding obligation of Subscriber and is enforceable against Subscriber in accordance with its terms, except as may be limited
or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, or other laws relating
to or affecting the rights of creditors generally and (ii) principles of equity, whether considered at law or equity (including
concepts of materiality, reasonableness, good faith, and fair dealing with respect to those jurisdictions that recognize such concepts).

 

2.1.3 
The execution, delivery and performance by Subscriber of this Subscription Agreement and the consummation of the transactions
contemplated herein do not and will not (i) conflict with or result in a breach or violation of any of the terms or provisions
of, or constitute a default under, or result in the creation or imposition of any lien, charge, or encumbrance upon any of the
property or assets of Subscriber or any of its subsidiaries, if any, pursuant to the terms of any indenture, mortgage, deed of
trust, loan agreement, lease, license, or other agreement or instrument to which Subscriber or any of its subsidiaries, if any,
is a party, or by which Subscriber or any of its subsidiaries, if any, is bound or to which any of the property or assets of Subscriber
or any of its subsidiaries, if any, is subject, which would reasonably be expected to have an adverse effect on the ability of
Subscriber to enter into and timely perform its obligations under, this Subscription Agreement (a “Subscriber Material
Adverse Effect”), (ii) result in any violation of the provisions of the organizational documents of Subscriber or any
of its subsidiaries, if any, or (iii) result in any violation of any law, statute or any judgment, order, rule, regulation or other
legally enforceable requirement of any court or governmental agency or body, domestic or foreign, having jurisdiction over Subscriber
or any of its subsidiaries, if any, or any of their respective properties that would reasonably be expected to have a Subscriber
Material Adverse Effect.

 

2.1.4 
Subscriber is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or
other person in connection with the execution, delivery and performance of this Subscription Agreement.

 

2.1.5 
Subscriber is (i) a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an
“accredited investor” (within the meaning of Rule 501(a) of Regulation D under the Securities Act) satisfying the applicable
requirements set forth on Schedule I attached hereto, (ii) an institutional account as defined in FINRA Rule 4512(c), (iii)
acquiring the Shares only for its own account and not for the account of others, or if Subscriber is subscribing for the Shares
as a fiduciary or agent for one or more investor accounts, each owner of such account is a qualified institutional buyer, and Subscriber
has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements,
representations, warranties, and agreements herein on behalf of each owner of each such account, and (iv) not acquiring the Shares
with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall
provide the requested information on Schedule I attached hereto). Subscriber is not an entity formed for the specific purpose
of acquiring the Shares.

 

2.1.6 
Subscriber is a sophisticated investor, experienced in investing in securities transactions and capable of evaluating investment
risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities,
and has exercised independent judgment in evaluating its participation in the purchase of the Shares.

 

    2

     

    

 

2.1.7 
 Subscriber understands that the Shares are being offered in a transaction not involving any public offering within the
meaning of the Securities Act and that the Shares have not been registered under the Securities Act. Subscriber understands that
the Shares may not be resold, transferred, pledged, or otherwise disposed of by Subscriber absent an effective registration statement
under the Securities Act, except (i) to the Issuer or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales
that occur solely outside the United States within the meaning of Regulation S under the Securities Act, or (iii) pursuant to another
applicable exemption from the registration requirements of the Securities Act, and in each of cases (i) and (iii), in accordance
with any applicable securities laws of the states and other jurisdictions of the United States, and that any certificates or book
entries representing the Shares (if any) shall contain a legend to such effect. Subscriber acknowledges that the Shares will not
be eligible for resale pursuant to Rule 144A promulgated under the Securities Act. Subscriber understands and agrees that the Shares
will be subject to the foregoing transfer restrictions and, as a result of these transfer restrictions, Subscriber may not be able
to readily resell the Shares and may be required to bear the financial risk of an investment in the Shares for an indefinite period
of time. Subscriber understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge, or
transfer of any of the Shares.

 

2.1.8 
Subscriber understands and agrees that Subscriber is purchasing the Shares directly from the Issuer. Subscriber further
acknowledges that there have been no representations, warranties, covenants, or agreements made to Subscriber by the Issuer, the
Company, the Placement Agents (as defined below) or any of their respective affiliates, officers or directors, expressly or by
implication, other than those representations, warranties, covenants, and agreements expressly set forth in this Subscription Agreement,
and Subscriber is not relying on any representations, warranties or covenants other than those expressly set forth in this Subscription
Agreement.

 

2.1.9 
Subscriber represents and warrants that it (i) is purchasing the Shares for investment, (ii) has no current plan or intention
to dispose of or otherwise transfer the Shares and (iii) is under no binding agreement to dispose of or otherwise transfer the
Shares.

 

2.1.10  2.1.10 If
Subscriber is an employee benefit plan that is subject to Title 1 of Employee Retirement Income Security Act of 1974, as
amended (“ERISA”), Subscriber represents and warrants that its acquisition and holding of the Shares will not
constitute or result in a non-exempt prohibited transaction under Section 406 of ERISAthe Employee Retirement Income Security
Act of 1974, as amended (“ERISA”), Section 4975 of the Internal Revenue Code of 1986, as amended (the
“Code”), or any applicable similar law. In making its decision to purchase the Shares, Subscriber represents that
it has relied solely upon independent investigation made by Subscriber and the Issuer’s representations, warranties and
agreements in Section 2.2 hereof. Without limiting the generality of the foregoing, Subscriber has not relied on any
statements or other information provided by anyone other than the Issuer concerning the Issuer, the Company or the Shares or
the offer and sale of the Shares. Subscriber acknowledges and agrees that Subscriber has received access to and has had an
adequate opportunity to review such financial and other information as Subscriber deems necessary in order to make an
investment decision with respect to the Shares, including with respect to the Issuer, the Company, and the Transactions and
has made its own assessment and is satisfied concerning the relevant tax and other economic considerations relevant to the
Subscriber’s investment in the Shares. Subscriber acknowledges that it has reviewed the SEC Documents (as defined
below). Subscriber represents and agrees that Subscriber and Subscriber’s professional advisor(s), if any, have had the
full opportunity to ask such questions, receive such answers, and obtain such information as Subscriber and such
Subscriber’s professional advisor(s), if any, have deemed reasonably necessary to make an investment decision with
respect to the Shares. Subscriber acknowledges that the Placement Agents (as defined below) and their respective directors,
officers, employees, representatives and controlling persons have made no independent investigation with respect to the
Issuer, the Company or the Shares or the accuracy, completeness or adequacy of any information supplied to the Subscriber by
the Issuer and/or the Company. Subscriber acknowledges that (i) it has not relied on any statements or other information
provided by any Placement Agent or any of the Placement Agents’ respective affiliates with respect to its decision to
invest in the Shares, including information related to the Issuer, the Company, the Shares and the offer and sale of the
Shares, (ii) none of the Placement Agents or any of their respective affiliates has prepared any disclosure or offering
document in connection with the offer and sale of the Shares and (iii) in connection with the issue and purchase of the
Shares, none of the Placement Agents has acted as the Subscriber’s financial advisor or fiduciary.

 

    3

     

    

 

2.1.11 
Subscriber became aware of this offering of the Shares solely by means of direct contact between Subscriber and the Issuer
or its representative. Subscriber has a pre-existing substantive relationship (as interpreted in guidance from the Commission (as
defined below) under the Securities Act) with the Issuer or its representative, and the Shares were offered to Subscriber solely
by direct contact between Subscriber and the Issuer or its representative. Subscriber did not become aware of this offering of
the Shares, nor were the Shares offered to Subscriber, by any other means. Subscriber acknowledges that it has not become aware
of this offering (i) by any form of general solicitation or general advertising, including methods described in Section 502(c)
of Regulation D under the Securities Act, or (ii) in a manner involving a public offering under, or in a distribution in violation
of, the Securities Act or any state securities laws.

 

2.1.12 
Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the
Shares. Subscriber is able to fend for itself in the transactions contemplated herein, has such knowledge and experience in financial
and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and Subscriber has sought
such accounting, legal, and tax advice as Subscriber has considered necessary to make an informed investment decision. The Subscriber
understands and acknowledges that the purchase and sale of the Shares hereunder meets (i) the exemptions from filing under FINRA
Rule 5123(b)(1)(A) and (ii) the institutional customer exemption under FINRA Rule 2111(b).

 

2.1.13 
Alone, or together with any professional advisor(s), if any, Subscriber has adequately analyzed and fully considered the
risks of an investment in the Shares and determined that the Shares are a suitable investment for Subscriber and that Subscriber
is able at this time and in the foreseeable future to bear the economic risk of a total loss of Subscriber’s investment in
the Issuer. Subscriber acknowledges specifically that a possibility of total loss exists.

 

2.1.14 
Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering
of the Shares or made any findings or determination as to the fairness of an investment in the Shares.

 

2.1.15  Neither
Subscriber nor any of its directors, officers, employees or other persons acting on behalf of Subscriber for the purposes of
this Subscription Agreement is (i) a person or entity named on the List of Specially Designated Nationals and Blocked
Persons, the Executive Order 13599 List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List,
each of which is administered by the U.S. Treasury Department’s Office of Foreign Assets Control
(“OFAC”) or in any other Executive Order issued by the President of the United States and administered by
OFAC (collectively, “OFAC Lists”), or a person or entity prohibited by any OFAC sanctions program, (ii)
owned or controlled by, or acting on behalf of, a person, that is named on an OFAC List; (iii) organized, incorporated,
established, located, resident or born in, or a citizen, national, or the government, including any political subdivision,
agency, or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, or any other country or
territory embargoed or subject to substantial trade restrictions by the United States, (iv) a Designated National as defined
in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services
indirectly to a non-U.S. shell bank. Subscriber agrees to provide law enforcement agencies, if requested thereby, such
records as required by applicable law; provided, that Subscriber is permitted to do so under applicable law.
Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.),
as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively, the “BSA/PATRIOT
Act”), that Subscriber maintains policies and procedures reasonably designed to comply with applicable obligations
under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required, it maintains policies and procedures
reasonably designed to ensure compliance with OFAC-administered sanctions programs, including for the screening of its
investors against the OFAC sanctions programs, including the OFAC Lists. Subscriber further represents and warrants that, to
the extent required, it maintains policies and procedures reasonably designed to ensure that the funds held by Subscriber and
used to purchase the Shares were legally derived.

 

    4

     

    

 

2.1.16 
If Subscriber is an employee benefit plan that is subject to Title I of ERISA, a plan, an individual retirement account
or other arrangement that is subject to Section 4975 of the Code or an employee benefit plan that is a governmental plan (as defined
in Section 3(32) of ERISA), a church plan (as defined in Section 3(33) of ERISA), a non-U.S. plan (as described in Section 4(b)(4)
of ERISA), or other plan that is not subject to the foregoing but may be subject to provisions under any other federal, state,
local, non-U.S., or other laws or regulations that are similar to such provisions of ERISA or the Code, or an entity whose underlying
assets are considered to include “plan assets” of any such plan, account, or arrangement (each, a “Plan”)
subject to the fiduciary or prohibited transaction provisions of ERISA or Section 4975 of the Code, Subscriber represents and warrants
that neither the Issuer nor any of its affiliates (the “Transaction Parties”) has acted as the Plan’s
fiduciary, or has been relied on for advice, with respect to its decision to acquire and hold the Shares, and none of the Transaction
Parties shall at any time be relied upon as the Plan’s fiduciary with respect to any decision to acquire, continue to hold,
or transfer the Shares.

 

2.1.17 
Subscriber is not currently (and at all times through Closing will refrain from being or becoming) a member of a “group”
(within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or any successor provision), including any group acting for the purpose of acquiring, holding, or disposing of
equity securities of the Issuer (within the meaning of Rule 13d-5(b)(1) under the Exchange Act).

 

2.1.18 
The Subscriber hereby acknowledges and agrees that it will not, nor will any person acting at the Subscriber’s direction
or pursuant to any understanding with the Subscriber, directly or indirectly offer, sell, pledge, contract to sell, sell any option,
engage in hedging activities or execute any “short sales” as defined in Rule 200 of Regulation SHO under the Exchange
Act, including all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of
prime brokerage or other similar financing arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements
(including on a total return basis), and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers,
of the Common Stock or the Shares until the consummation of the Transactions (or such earlier termination of this Subscription
Agreement in accordance with its terms).

 

2.1.19 
 No foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign
state have a substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in the Issuer as a
result of the purchase and sale of Shares hereunder such that a declaration to the Committee on Foreign Investment in the United
States would be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208)
over the Issuer from and after the Closing as a result of the purchase and sale of Shares hereunder.

 

2.1.20 
Subscriber has, and on each date the Purchase Price would be required to be funded to the Issuer pursuant to Section
3 will have, sufficient immediately available funds to pay the Purchase Price pursuant to Section 3. Subscriber is an
entity having total liquid assets and net assets in excess of the Purchase Price as of the date hereof and as of each date the
Purchase Price would be required to be funded to the Issuer pursuant to Section 3.

 

    5

     

    

 

2.1.21 
The Subscriber hereby acknowledges that it has been informed that (a) each of J.P. Morgan Securities LLC (“J.P.
Morgan”) and Wells Fargo Securities, LLC (“Wells Fargo” and together with J.P. Morgan, in their respective
capacities as placement agents with respect to the issuance and sale of the Shares pursuant to this Subscription Agreement and
the Other Subscription Agreements, the “Placement Agents”) is each acting solely as Placement Agent in connection
with the Transactions and is not acting as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary
for the undersigned, the Company or any other person or entity in connection with the Transactions, (b) the Placement Agents have
not made and will not make any representation or warranty, whether express or implied, of any kind or character and have not provided
any advice or recommendation in connection with the Transactions, (c) the Placement Agents will have no responsibility with respect
to (i) any representations, warranties or agreements made by any person or entity under or in connection with the Transactions
or any of the documents furnished pursuant thereto or in connection therewith, or the execution, legality, validity or enforceability
(with respect to any person) of any thereof, or (ii) the business, affairs, financial condition, operations, properties or prospects
of, or any other matter concerning the Company or the Transactions, and (d) the Placement Agents shall have no liability or obligation
(including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities,
costs, expenses or disbursements incurred by the Subscriber, the Company or any other person or entity), whether in contract, tort
or otherwise, to the Subscriber, or to any person claiming through the Subscriber, in respect of the Transactions.

 

2.1.22 
No broker, finder, or other financial consultant has acted on behalf of or at the direction of Subscriber in connection
with this Subscription Agreement or the transactions contemplated hereby in such a way as to create any liability on the Issuer,
the Company or any of their respective subsidiaries.

 

2.2 
Issuer’s Representations, Warranties, and Agreements. For purposes of this Section 2.2, the term “Issuer”
shall refer to the Issuer as of the date hereof and, for purposes of only the representations contained in Sections 2.2.5,
2.2.9, 2.2.15, 2.2.17 and 2.2.18 and to the extent such representations and warranties are made as of the Closing, the combined
company after giving effect to the Transactions. To induce Subscriber to purchase the Shares, the Issuer hereby represents and
warrants to Subscriber and agrees with Subscriber as follows:

 

2.2.1  The
Issuer has been duly incorporated and is validly existing as a corporation in good standing under the laws of the Delaware
General Corporation Law (“DGCL”), with corporate power and authority to own, lease, and operate its
properties and conduct its business as presently conducted and to enter into, deliver, and perform its obligations under this
Subscription Agreement.

 

    6

     

    

 

2.2.2 
The Shares have been duly authorized and, when issued and delivered to Subscriber against full payment for the Shares will
be free and clear of any liens or other restrictions whatsoever in accordance with the terms of this Subscription Agreement and
registered with the Issuer’s transfer agent, the Shares will be validly issued, fully paid, and non-assessable, and will
not have been issued in violation of or subject to any preemptive or similar rights created under the Issuer’s amended and
restated certificate of incorporation or under the DGCL or otherwise.

 

2.2.3 
This Subscription Agreement has been duly authorized and validly executed and delivered by the Issuer and, assuming that
this Subscription Agreement has been duly authorized, executed and delivered by Subscriber, is the valid and binding obligation
of the Issuer and is enforceable against the Issuer in accordance with its terms, except as may be limited or otherwise affected
by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, or other laws relating to or affecting the rights
of creditors generally and (ii) principles of equity, whether considered at law or equity (including concepts of materiality, reasonableness,
good faith, and fair dealing with respect to those jurisdictions that recognize such concepts).

 

2.2.4 
The execution, delivery, and performance of this Subscription Agreement (including compliance by the Issuer with all of
the provisions hereof), issuance and sale of the Shares, and the consummation of the Transactions and certain other transactions
contemplated herein will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute
a default under, or result in the creation or imposition of any lien, charge, or encumbrance upon any of the property or assets
of the Issuer or any of its subsidiaries pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement, lease,
license, or other agreement or instrument to which the Issuer or any of its subsidiaries is a party or by which the Issuer or any
of its subsidiaries is bound or to which any of the property or assets of the Issuer or any of its subsidiaries is subject, which
would reasonably be expected to have a Material Adverse Effect (as defined in the Merger Agreement) or a material adverse effect
on the assets, business, results of operation or financial operations of the Issuer and its subsidiaries, taken as a whole (including
the combined company after giving effect to the Transaction), or prevents, materially impairs, materially delays or materially
impedes the legal authority of the Issuer to enter into and timely perform its obligations under this Subscription Agreement or
the Merger Agreement or to consummate the Transactions or the validity or enforceability of the Shares (collectively, an “Issuer
Material Adverse Effect”), (ii) result in any violation of the provisions of the organizational documents of the Issuer
or any of its subsidiaries, or (iii) result in any violation of any law, statute or any judgment, order, rule, regulation or other
legally enforceable requirement of any court or governmental agency or body, domestic or foreign, having jurisdiction over the
Issuer or any of its subsidiaries or any of its and their respective properties that would reasonably be expected to have an Issuer
Material Adverse Effect.

 

2.2.5  The
Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority or self-regulatory organization
in connection with the execution, delivery and performance of this Subscription Agreement or the Transactions (including,
without limitation, the issuance of the Shares), other than (i) filings with the Securities and Exchange Commission (the
“Commission”), (ii) filings required by applicable state securities laws, (iii) any filings required under
the Hart-Scott-Rodino Antitrust Improvements Act of 1976 or similar antitrust laws, (iv) filings required by Nasdaq Stock
Market LLC (“Nasdaq”), including with respect to obtaining Issuer stockholder approval, (v) consents,
waivers, authorizations or filings that have been obtained or made on or prior to the Subscription, and (vi) where the
failure of which to obtain would not reasonably be expected to have an Issuer Material Adverse Effect or have a material
adverse effect on the Issuer’s ability to consummate the transactions contemplated hereby, including the issuance and
sale of the Shares.

 

    7

     

    

 

2.2.6 
Concurrently with the execution and delivery of this Subscription Agreement, the Issuer is entering into the Other Subscription
Agreements providing for the sale of an aggregate of [●] Shares for an aggregate value equal to $[●] (including the
Shares purchased and sold under this Subscription Agreement). There are no Other Subscription Agreements, side letter agreements
or other agreements or understandings (including written summaries of any oral understandings) with any Other Subscriber or any
other investor or potential investor with respect to the purchase of equity securities of the Issuer (other than pursuant to the
Merger Agreement) which include economic terms that are materially more advantageous to any such Other Subscriber, investor or
potential investor (as compared to Subscriber).

 

2.2.7 
Assuming the accuracy of Subscriber’s representations and warranties set forth in Section 2.1 of this Subscription
Agreement and each of the Other Subscription Agreements, no registration under the Securities Act is required for the offer and
sale of the Shares by the Issuer to Subscriber and the Other Subscribers pursuant to the Other Subscription Agreements.

 

2.2.8 
The Issuer is, and since its date of incorporation, has been, operating in all material respects in a manner that is customary
for businesses similar to the Issuer, and the Issuer is conducting and, since its date of incorporation, has conducted its business
in material compliance with all applicable laws.

 

2.2.9 
The Issuer is in compliance with all applicable laws, except where such non-compliance would not have a Material Adverse
Effect. The Issuer has not received any written, or to its knowledge, other communication from a governmental entity that alleges
that the Issuer is not in compliance with or is in default or violation of any applicable law, except where such non-compliance,
default or violation would not, individually or in the aggregate, have an Issuer Material Adverse Effect.

 

2.2.10 
The issued and outstanding shares of Common Stock of the Issuer are registered pursuant to Section 12(b) of the Exchange
Act and are listed for trading on the Nasdaq under the symbol “GWAC” (it being understood that the trading symbol will
be changed in connection with the Closing). There is no suit, action, proceeding or investigation pending or, to the knowledge
of the Issuer, threatened against the Issuer by Nasdaq or the Commission, respectively, to prohibit or terminate the listing of
the Issuer’s Common Stock on Nasdaq or to deregister the Common Stock under the Exchange Act. The Issuer has taken no action
that is designed to terminate, or that would reasonably be expected to result in the termination of the registration of the Common
Stock under the Exchange Act.

 

2.2.11  The
Issuer has made available to Subscriber (including via the Commission’s EDGAR system) a true, correct, and complete
copy of each form, report, statement, schedule, prospectus, proxy, registration statement, and other documents filed by the
Issuer with the Commission prior to the date of this Subscription Agreement (the “SEC Documents”). None of
the SEC Documents filed under the Exchange Act, contained, when filed or, if amended prior to the date of this Subscription
Agreement, as of the date of such amendment with respect to those disclosures that are amended, any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading. The Issuer has timely filed each report, statement,
schedule, prospectus, and registration statement that the Issuer was required to file with the Commission since its inception
and through the date hereof. There are, and upon Closing there shall be, no material outstanding or unresolved comments in
comment letters from the Commission staff with respect to any of the SEC Documents.

 

    8

     

    

 

2.2.12 
The Proxy Statement (as defined in the Merger Agreement), when filed or, if amended, as of the date of such amendment with
respect to those disclosures that are amended, will not include any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading.

 

2.2.13 
As of the date hereof and as of immediately prior to the Transactions, the authorized capital stock of the Issuer is 100,000,000
shares, consisting of (a) 100,000,000 shares of Common Stock, par value $0.001 per share, and (b) 1,000,000 shares of preferred
stock, par value $0.001 per share (the “Preferred Shares”). As of the date hereof: (i) no Preferred Shares are
issued and outstanding; (ii) 21,478,000 shares of Common Stock are issued and outstanding; and (iii) 8,614,000 warrants to purchase
shares of Common Stock (the “Warrants”) are outstanding. All (A) issued and outstanding shares of Common Stock
have been duly authorized and validly issued, are fully paid and are non-assessable and are not subject to preemptive rights and
(B) outstanding Warrants have been duly authorized and validly issued, are fully paid and are not subject to preemptive rights.
Except as set forth above and pursuant to the Other Subscription Agreements and the Merger Agreement, there are no outstanding
options, warrants or other rights to subscribe for, purchase or acquire from the Issuer any shares of Common Stock, or any other
equity interests in the Issuer, or securities convertible into or exchangeable or exercisable for such equity interests. There
are no securities or instruments issued by or to which the Issuer is a party containing anti-dilution or similar provisions that
will be triggered by the issuance of the Shares or the shares to be issued pursuant to any Other Subscription Agreement, that have
not been or will not be validly waived on or prior to the Closing Date.

 

2.2.14 
The Issuer is not, and immediately after receipt of payment for the Shares will not be, an “investment company”
within the meaning of the Investment Company Act of 1940.

 

2.2.15 
Neither the Issuer nor, to the knowledge of the Issuer, any of its officers, in their capacities as such, or the Company,
is the subject of or engaged in any action before a governmental authority, arbitration or other dispute resolution process before
a third party unrelated to the dispute, whether as claimant, defendant or otherwise, and no such litigation, arbitration or dispute
resolution process is pending or threatened in writing on the date hereof, in each case, that would, individually or in the aggregate,
reasonably be expected to have an Issuer Material Adverse Effect. As of the date hereof, the Issuer is not, nor to the knowledge
of the Issuer is any of its officers, in their capacities as such, or the Company, subject to any settlement agreements or arrangements,
whether written or oral, or is in discussions for a settlement or arrangement, regarding any disputes or claims, in each case,
that would, individually or in the aggregate, reasonably be expected to have an Issuer Material Adverse Effect. As of the date
of this Subscription Agreement, neither the Issuer nor the Company is a party to or subject to the provisions of any outstanding
or unsatisfied judgment, order, writ, injunction, decree or award of any governmental authority (except if generally applicable
without the Issuer being named therein) that would, individually or in the aggregate, reasonably be expected to have an Issuer
Material Adverse Effect.

 

2.2.16  Other
than to the Placement Agents, no broker, finder, or other financial consultant has acted on behalf of or at the direction of
the Issuer in connection with this Subscription Agreement or the transactions contemplated hereby in such a way as to create
any liability on Subscriber.

 

    9

     

    

 

2.2.17 
Neither the Issuer nor any person acting on its behalf has engaged or will engage in any form of general solicitation or
general advertising (within the meaning of Regulation D of the Securities Act) in connection with any offer or sale of the Shares,
and are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act
or any state securities laws.

 

2.2.18 
Except as would not reasonably be expected to have an Issuer Material Adverse Effect, (i) the Issuer and its subsidiaries
own or possess valid and adequate rights to use any and all patents, patent applications, trademarks, service marks, trade names,
trademark registrations, service mark registrations, copyrights, licenses and know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures) used in or necessary for the conduct of their
respective businesses as presently conducted and as described and as proposed to be conducted, in the SEC Documents, (ii) the conduct
of their respective businesses does not conflict in any material respect with any such rights of others, and (iii) the Issuer and
its subsidiaries have not received any written notice of any claim of infringement, misappropriation or violation of, or conflict
with, any intellectual property right of others.

 

2.2.19 
Since its date of incorporation, neither the Issuer nor, to the Issuer’s knowledge, any of its representatives, have
directly or indirectly paid, offered or promised to pay, or authorized or ratified the payment, directly or indirectly, of any
monies or anything of value to any national, provincial, municipal or other government official or any political party or candidate
for political office for the purpose of influencing any act or decision of such official or of any governmental authority to obtain
or retain business, or direct business to any person or to secure any other improper benefit or advantage in each case in violation
in any material respect any Anti-Corruption Laws (as defined in the Merger Agreement). The Issuer (x) has instituted policies and
procedures designed to ensure compliance with the Anti-Corruption Laws and other anti-bribery, anti-corruption and anti-money
laundering laws in each jurisdiction in which the Issuer operates and (y) has maintained such policies and procedures in force.
To the Issuer’s knowledge, no government official nor any of his or her immediate family members is an officer or director
or owns any securities of the Issuer. Since its date of incorporation, neither the Issuer nor, to the Issuer’s knowledge,
any of its representatives, has, or is presently or has agreed to become, engaged in any conduct that violates in any material
respect any applicable Anti-Corruption Laws. Since its date of incorporation, to the Issuer’s knowledge, the Issuer is not
conducting and has not conducted, directly or indirectly, any business (including, without limitation, sales, reselling, licensing
or sub-licensing arrangements, funding, making payments, procuring, insurance or otherwise providing assistance or support
in connection with operations, business or any other activity) with or for the direct or indirect benefit of or on behalf of any
Sanctioned Person (as defined in the Merger Agreement), nor otherwise violated any applicable Sanction (as defined in the Merger
Agreement) or Ex-Im Law (as defined in the Merger Agreement).

 

2.2.20 
As of the date hereof, all representations and warranties of the Company that are contained in the Merger Agreement are
true and correct in all material respects, to the knowledge of the Issuer after due inquiry.

 

    10

     

    

 

3. 
Settlement Date and Delivery; Closing Conditions.

 

3.1.1 
 The closing of the Subscription contemplated hereby (the “Closing”) is contingent upon the substantially
concurrent consummation of the Transactions and shall occur immediately prior to and is conditional upon the subsequent occurrence
of, consummation of the Transactions. Upon written notice from (or on behalf of) the Issuer to Subscriber (the “Closing
Notice”) at least four (4) Business Days prior to the date that the Issuer reasonably expects all conditions to the closing
of the Transactions to be satisfied or waived (the “Expected Closing Date”), Subscriber shall deliver to the
Issuer, no later than one (1) Business Day prior to the Expected Closing Date, (x) the Purchase Price for the Shares by wire transfer
of United States dollars in immediately available funds to the account specified by the Issuer in the Closing Notice, such funds
to be held by the Issuer in escrow until the Closing and (y) such information as is reasonably requested in the Closing Notice
in order for the Issuer to issue the Shares to Subscriber, including the legal name of the person in whose name the Shares are
to be issued and a duly completed and executed Internal Revenue Service Form W-9 or an appropriate duly completed and executed
Internal Revenue Service Form W-8. If the Transactions are not consummated on or prior to the fifth (5th) Business Day after the
Expected Closing Date, the Issuer shall return the Purchase Price (which shall not include, for the avoidance of doubt, the accrual
of any interest) to Subscriber by wire transfer of United States dollars in immediately available funds to an account specified
by Subscriber. Notwithstanding such return, Subscriber shall remain obligated to redeliver funds representing the Purchase Price
to the Issuer following the Issuer’s delivery to Subscriber of a new Closing Notice. Unless otherwise agreed by the Company
in writing, the Issuer shall deliver the Closing Notice at least four (4) Business Days prior to the date of the Special Meeting.
At the Closing, the Issuer shall deliver to Subscriber (i) the Shares in book entry form, free and clear of any liens or other
restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein or in any other
agreement between the Issuer and the Subscriber), in the name of Subscriber (or its nominee in accordance with its delivery instructions)
and (ii) a copy of the records of the Issuer’s transfer agent showing the Subscriber (or such nominee or custodian) as the
owner of the Shares on and as of the Closing. For purposes of this Subscription Agreement, “Business Day” means
a day other than a Saturday, Sunday, or other day on which commercial banks in New York, New York are authorized or required by
law to close. Upon delivery in book-entry form of the Shares to the Subscriber (or its nominee, if applicable), the Purchase Price
may be released from escrow.

 

3.1.2 
The obligations of the Issuer to consummate the transactions contemplated hereunder are subject to the satisfaction (or
waiver by the Issuer in writing) of the conditions that, at the Closing:

 

(1) 
all representations and warranties of the Subscriber contained in this Subscription Agreement shall be true and correct
in all material respects (other than representations and warranties that are qualified as to materiality which representations
and warranties shall be true and correct in all respects) at and as of the Closing, and consummation of the Closing shall constitute
a reaffirmation by the Subscriber of each of the representations, warranties and agreements of such party contained in this Subscription
Agreement as of the Closing; and

 

(2) 
Subscriber shall have performed or complied in all material respects with all agreements and covenants required by this
Subscription Agreement required to be performed or complied with at or prior to the Closing, except where the failure of such performance
or compliance would not reasonably be expected to prevent, materially delay, or materially impair the ability of the Subscriber
to consummate the Closing.

 

    11

     

    

 

3.1.3 
 The obligations of the Subscriber to consummate the transactions contemplated hereunder are subject to the satisfaction
(or waiver by the Subscriber in writing) of the conditions that, at the Closing:

 

(1) 
all representations and warranties of the Issuer contained in this Subscription Agreement shall be true and correct in all
material respects (other than representations and warranties that are qualified as to materiality or an Issuer Material Adverse
Effect, which representations and warranties shall be true and correct in all respects) at and as of the Closing, and consummation
of the Closing shall constitute a reaffirmation of each of the applicable representations, warranties and agreements of the Issuer
and the combined company contained in this Subscription Agreement as of the Closing;

 

(2) 
the Issuer shall have performed or complied in all material respects with all agreements and covenants required by this
Subscription Agreement required to be performed or complied with at or prior to the Closing, except where the failure of such performance
or compliance would not or would not reasonably be expected to prevent, materially delay, or materially impair the ability of the
Issuer to consummate the Closing;

 

(3) 
no suspension of the qualification of the Common Stock for offering or sale or trading in any jurisdiction, or initiation
or threatening of any proceedings for any such purposes shall have occurred, and the Shares shall have been approved for listing
on Nasdaq (subject to official notice of issuance); and

 

(4) 
the Merger Agreement shall not have been amended to, and there shall have been no waiver or modification to the Merger Agreement
that would, materially and adversely affect the undersigned relative to the economic benefits that the Subscriber would reasonably
expect to receive under this Subscription Agreement without the Subscriber’s prior written consent.

 

3.1.4 
The obligations of each of the Issuer and the Subscriber to consummate the transactions contemplated hereunder are subject
to the satisfaction of the conditions that, at the Closing:

 

(1) 
no governmental authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any law,
rule, regulation, judgment, decree, executive order or award after the date hereof which is then in effect and has the effect of
making the Subscription illegal or otherwise prohibiting consummation of the Subscription;

 

(2) 
all conditions precedent to the closing of the Transactions set forth in the Merger Agreement, including all necessary approvals
of the Issuer’s stockholders and regulatory approvals, if any, shall have been satisfied or waived (other than those conditions
that may only be satisfied at the closing of the Transactions, but subject to the satisfaction or waiver of such conditions as
of the closing of the Transactions); and

 

(3) 
the Transactions shall have been or will be consummated concurrently with the Closing.

 

    12

     

    

 

4. 
 Registration Statement.

 

4.1 
The Issuer agrees that, within thirty (30) calendar days after the consummation of the Transactions (the “Filing
Date”), the Issuer will file with the Commission (at the Issuer’s sole cost and expense) a registration statement
(the “Registration Statement”) registering the resale of the Shares (the “Registrable Securities”),
and the Issuer shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable
after the filing thereof (such date, the “Effectiveness Date”); provided, however, that the
Issuer’s obligations to include the Registrable Securities in the Registration Statement are contingent upon Subscriber furnishing
a completed and executed selling shareholders questionnaire in customary form to the Issuer that contains the information required
by Commission rules for a Registration Statement regarding Subscriber, the securities of the Issuer held by Subscriber, and the
intended method of disposition of the Registrable Securities to effect the registration of the Registrable Securities, and Subscriber
shall execute such documents in connection with such registration as the Issuer may reasonably request that are customary of a
selling stockholder in similar situations, including providing that the Issuer shall be entitled to postpone and suspend the effectiveness
or use of the Registration Statement during any customary blackout or similar period or as permitted hereunder; provided that the
Subscriber shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject
to any contractual restriction on the ability to transfer the Shares. Any failure by the Issuer to file the Registration Statement
by the Filing Date or to effect such Registration Statement by the Effectiveness Date shall not otherwise relieve the Issuer of
its obligations to file or effect the Registration Statement as set forth above in this Section 4. Unless required under
applicable laws and Commission rules, in no event shall the Subscriber be identified as a statutory underwriter in the Registration
Statement; provided, that if the Subscriber is required to be so identified as a statutory underwriter in the Registration Statement,
the Subscriber will have an opportunity to withdraw its Registrable Securities from the Registration Statement.

 

4.2 
In the case of the registration effected by the Issuer pursuant to this Subscription Agreement, the Issuer shall, upon reasonable
request, inform Subscriber as to the status of such registration. At its expense, the Issuer shall:

 

4.2.1 
except for such times as the Issuer is permitted hereunder to suspend the use of the prospectus forming part of a Registration
Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption, or compliance under
state securities laws which the Issuer determines to obtain, continuously effective with respect to Subscriber, and to keep the
applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions,
until the earlier of the following: (i) Subscriber ceases to hold any Registrable Securities; (ii) the date all Registrable Securities
held by Subscriber may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale
restrictions which may be applicable to affiliates under Rule 144 and without the requirement for the Issuer to be in compliance
with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) and (iii) three years from
the date of the effectiveness of the Registration Statement;

 

4.2.2 
advise Subscriber as expeditiously as reasonably possible (and not later than within three (3) Business Days)::

 

(a) when
a Registration Statement or any post-effective amendment thereto has become effective;

 

    13

     

    

 

(b) after
it shall receive notice or obtain knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for such purpose;

 

(c) of
the receipt by the Issuer of any notification with respect to the suspension of the qualification of the Registrable Securities
included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(d) subject
to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any
Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the
light of the circumstances under which they were made) not misleading.

 

Notwithstanding
anything to the contrary set forth herein, the Issuer shall not, when so advising Subscriber of such events, provide Subscriber
with any material, nonpublic information regarding the Issuer other than to the extent that providing notice to Subscriber of the
occurrence of the events listed in (a) through (d) above may constitute material, nonpublic information regarding the Issuer;
Subscriber hereby consents to receipt of any material, non-public information with respect to the occurrence of the events listed
in (a) through (d) above;

 

4.2.3 
use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration
Statement as soon as reasonably practicable;

 

4.2.4 
upon the occurrence of any event contemplated in Section 4.2.2(d), except for such times as the Issuer is permitted
hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Issuer shall use
its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration
Statement or a supplement to the related prospectus, or file any other required document, so that, as thereafter delivered to purchasers
of the Registrable Securities included therein, such prospectus will not include any untrue statement of a material fact or omit
to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading; and

 

4.2.5 
use its commercially reasonable efforts to cause all Shares to be listed on each securities exchange or market, if any,
on which the Issuer’s Common Stock is then listed.

 

4.3 
Notwithstanding anything to the contrary in this Subscription Agreement, if the Commission prevents the Issuer from including
in the Registration Statement any or all of the Shares due to limitations on the use of Rule 415 of the Securities Act for the
resale of the Shares by the Subscriber, the Registration Statement shall register for resale such number of Shares which is equal
to the maximum number of Shares as is permitted by the Commission. In such event, the number of Shares to be registered for each
selling stockholder named in the Registration Statement shall be reduced pro rata among all such selling stockholders and as promptly
as practicable after being permitted to register additional Shares under Rule 415 under the Securities Act, the Issuer shall use
commercially reasonable efforts to amend the Registration Statement or file a new Registration Statement to register such Shares
not included in the initial Registration Statement.

 

    14

     

    

 

4.4 
 Notwithstanding anything to the contrary in this Subscription Agreement, the Issuer shall be entitled to delay or postpone
the effectiveness of the Registration Statement, and from time to time to require Subscriber not to sell under the Registration
Statement or to suspend the effectiveness thereof, if it determines that in order for the Registration Statement not to contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein not
misleading, (i) an amendment thereto would be needed to include information that would at that time not otherwise be required in
a current, quarterly, or annual report under the Exchange Act, (ii) the negotiation or consummation of a transaction by Issuer
or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event Issuer’s board of directors
reasonably believes would require additional disclosure by Issuer in the Registration Statement of material information that Issuer
has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement
would be expected, in the reasonable determination of Issuer’s board of directors to cause the Registration Statement to
fail to comply with applicable disclosure requirements (each such circumstance, a “Suspension Event”);
provided, however, that the Issuer may not delay or suspend the Registration Statement on more than two (2) occasions
or for more than forty-five (45) consecutive calendar days, or more than ninety (90) total calendar days, in each case during any
twelve (12) month period. Upon receipt of any written notice from the Issuer of the happening of any Suspension Event during the
period that the Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or related
prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made (in the case of the prospectus)
not misleading, Subscriber agrees that (a) it will immediately discontinue offers and sales of the Shares under the Registration
Statement until Subscriber receives copies of a supplemental or amended prospectus (which the Issuer agrees to promptly prepare)
that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment has become
effective or unless otherwise notified by the Issuer that it may resume such offers and sales, and (b) it will maintain the confidentiality
of any information included in such written notice delivered by the Issuer as required by law. If so directed by the Issuer, Subscriber
will deliver to the Issuer or, in Subscriber’s sole discretion destroy, all copies of the prospectus covering the Shares
in Subscriber’s possession; provided, however, that this obligation to deliver or destroy all copies of
the prospectus covering the Shares shall not apply (1) to the extent Subscriber is required to retain a copy of such prospectus
(A) in order to comply with applicable legal, regulatory, self-regulatory, or professional requirements, or (B) in accordance with
a bona fide pre-existing document retention policy, or (2) to copies stored electronically on archival servers as a result of automatic
data back-up.

 

5. 
Termination. Except for the provisions of this Section 5 and Section 6, which shall survive any termination
hereunder, this Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations
of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest
to occur of (i) the Merger Agreement is validly terminated in accordance with its terms, (ii) upon the mutual written agreement
of the Company and each of the parties hereto to terminate this Subscription Agreement and (iii) the date that is six months from
the date hereof, if the Closing has not occurred by such date;; provided, that nothing herein will relieve any party from
liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law
or in equity to recover losses, liabilities, or damages arising from such breach. The Issuer shall promptly notify Subscriber of
the termination of the Merger Agreement promptly after the termination of such agreement (if applicable), and any monies paid by
the Subscriber to the Issuer in connection herewith shall promptly (and in any event within one (1) Business Day) following a termination
be returned to the Subscriber without any deduction for or on account of any tax withholding, charges or set-off, in each case,
to the extent permitted by law.

 

    15

     

    

 

6. 
Miscellaneous.

 

6.1 
Further Assurances. The parties hereto shall execute and deliver such additional documents and take such additional actions
as the parties reasonably may deem to be practical and necessary in order, or cause to be taken, all things necessary, proper or
advisable to consummate the Subscription as contemplated by this Subscription Agreement on the terms and conditions described herein
no later than immediately prior to the Closing.

 

6.1.1 
Subscriber acknowledges that the Issuer, the Company, and others will rely on the acknowledgments, understandings, agreements,
representations, and warranties made by Subscriber contained in this Subscription Agreement. Prior to the Closing, Subscriber agrees
to promptly notify the Issuer and the Company if any of the acknowledgments, understandings, agreements, representations, and warranties
set forth herein are no longer accurate in all material respects.

 

6.1.2 
Each of the Issuer, Subscriber, and the Company is entitled to rely upon this Subscription Agreement and is irrevocably
authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding
or official inquiry with respect to the matters covered hereby.

 

6.1.3 
The Issuer may request from Subscriber such additional information as the Issuer may reasonably deem necessary to evaluate
the eligibility of Subscriber to acquire the Shares, and Subscriber shall promptly provide such information as may be reasonably
requested to the extent readily available and to the extent consistent with its internal policies and procedures; provided that
the Issuer expressly agrees to keep any such information provided by the Subscriber confidential, except as required by the applicable
securities laws or pursuant to proceedings of regulatory authorities.

 

6.1.4 
Subscriber shall pay all of its own expenses in connection with this Subscription Agreement and the transactions contemplated
herein.

 

6.1.5 
Each of Subscriber and the Issuer shall take, or cause to be taken, all actions and do, or cause to be done, all things
necessary, proper, or advisable to consummate the transactions contemplated by this Subscription Agreement on the terms and conditions
described therein no later than immediately prior to the consummation of the Transactions.

 

6.2 
Notices. Any notice or communication required or permitted hereunder shall be in writing and either delivered personally,
emailed, sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and
shall be deemed to be given and received (i) when so delivered personally, (ii) when sent, with no mail undeliverable or other
rejection notice, if sent by email, or (iii) three (3) Business Days after the date of mailing to the address below or to such
other address or addresses as such person may hereafter designate by notice given hereunder:

 

		(a)	if to Subscriber, to such address or addresses set forth on Subscriber’s signature page hereto;

 

    16

     

    

 

		(b)	if to the Issuer, to:

 

Good Works Acquisition Corp.

4265 San Felipe

Houston, TX 77027

Attention: Cary Grossman

Email: cgrossman@shorelinecapitaladvisors.com

 

with a required copy (which copy shall
not constitute notice) to:

 

Schiff Hardin LLP

901 K Street NW Suite 700

Washington, DC 20001]

Attention: Ralph De Martino

Email: rdemartino@schiffhardin.com

 

		(c)	if to the Company, to:

 

Cipher Mining
Technologies Inc.

222 Purchase Street, #290

Rye, NY 10580

United States of America

 

Attn: 
Tyler Page

E-mail: Tyler.page@ciphermining.com  

 

with a copy (which shall not constitute
notice) to:

 

Latham & Watkins (London) LLP

99 Bishopsgate

London, EC2M 3XF

United Kingdom

Attn:   J. David Stewart

             Ryan
Maierson

E-mail:  j.david.stewart@lw.com

ryan.maierson@lw.com

 

6.3 
Entire Agreement. This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements,
understandings, representations, and warranties, both written and oral, among the parties, with respect to the subject matter hereof,
including any commitment letter entered into relating to the subject matter hereof.

 

6.4 
Modifications; Amendments; Waivers. This Subscription Agreement may not be amended, modified, supplemented, or waived
(i) except by an instrument in writing, signed by the party against whom enforcement of such amendment, modification, supplement,
or waiver is sought and (ii) without the prior written consent of the Company. No failure or delay of either party in exercising
any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or
power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other
or further exercise thereto or the exercise of any other right or power.

 

    17

     

    

 

6.5 
 Assignment. Neither this Subscription Agreement nor any rights, interests, or obligations that may accrue to the
parties hereunder (including Subscriber’s rights to purchase the Shares) may be transferred or assigned without the prior
written consent of each of the Company and the other party hereto (other than the Shares acquired hereunder and then only in accordance
with this Subscription Agreement).

 

6.6 
Benefit.

 

6.6.1 
Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the
parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements,
representations, warranties, covenants, and acknowledgments contained herein shall be deemed to be made by, and be binding upon,
such heirs, executors, administrators, successors, legal representatives, and permitted assigns. The parties hereto agree that
each of the Company and its subsidiaries are express third-party beneficiaries (the “Beneficiaries”) of this
Subscription Agreement. Each of the parties hereto acknowledge and agree that (i) each of the Beneficiaries shall be entitled to
seek and obtain equitable relief, without proof of actual damages, including an injunction or injunctions or order for specific
performance to prevent breaches of this Subscription Agreement and to enforce specifically the terms and provisions of this Subscription
Agreement to cause the Issuer to cause, or directly cause, Subscriber to fund the Purchase Price and cause the Closing to occur
substantially concurrently with the Transactions, and (ii) without in any way limiting the foregoing, the Company is an express-third
party beneficiary of Sections 3 (Closing), 5, (Termination), 6.1 (Further Assurances),
6.4 (Modifications and Amendments), 6.5 (Assignment), 6.11 (Remedies) and 7.2
(Cleansing Statement; Disclosure ) and shall be entitled to seek and obtain equitable relief, without proof of actual damages,
including an injunction or injunctions or order for specific performance to prevent breaches of its rights referenced therein.
Each party hereto further agrees that each of the Beneficiaries is an express third-party beneficiary of this Section 6.6
and that none of the parties hereto or any of the Beneficiaries shall be required to obtain, furnish, or post any bond or similar
instrument in connection with or as a condition to obtaining any remedy referred to in this Section 6.6.1, and each party
hereto irrevocably waives any right it may have to require the obtaining, furnishing, or posting of any such bond of similar instrument.

 

6.6.2 
Each of the Issuer and Subscriber acknowledges and agrees that (i) this Subscription Agreement is being entered into in
order to induce each of the parties to the Merger Agreement to execute and deliver the Merger Agreement and without the representations,
warranties, covenants, and agreements of the Issuer and Subscriber hereunder, the Company would not enter into the Merger Agreement,
and (ii) each representation, warranty, covenant, and agreement of the Issuer and Subscriber hereunder is being made also for the
benefit of the Company and the Beneficiaries.

 

6.6.3 
Each of the Issuer and Subscriber further acknowledge and agree that the Placement Agents are third-party beneficiaries
of the representations and warranties of the Issuer and Subscriber contained in this Subscription Agreement.

 

6.7 
Governing Law. This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of
or related to this Subscription Agreement (whether based on law, in equity, in contract, in tort, or any other theory) or the negotiation,
execution, performance, or enforcement of this Subscription Agreement, shall be governed by and construed in accordance with the
internal laws of the State of Delaware, including its statute of limitations, without giving effect to principles or rules of conflicts
of law thereof to the extent they would require or permit the application of laws or statute of limitations of another jurisdiction.

 

    18

     

    

 

6.8 
 Consent to Jurisdiction; Waiver of Jury Trial. Each of the parties irrevocably consents to the exclusive jurisdiction
and venue of the Court of Chancery of the State of Delaware; provided, that if subject matter jurisdiction over the matter
that is the subject of the legal proceeding is vested exclusively in the U.S. federal courts, such legal proceeding shall be heard
in the U.S. District Court for the District of Delaware (together with the Court of Chancery of the State of Delaware, the “Chosen
Courts”), in connection with any matter based upon or arising out of this Subscription Agreement. Each party hereby waives,
and shall not assert as a defense in any legal dispute, that (i) such person is not personally subject to the jurisdiction of the
Chosen Courts for any reason, (ii) such legal proceeding may not be brought or is not maintainable in the Chosen Courts, (iii)
such person’s property is exempt or immune from execution, (iv) such legal proceeding is brought in an inconvenient forum,
or (v) the venue of such legal proceeding is improper. Each party hereby consents to service of process in any such proceeding
in any manner permitted by Delaware law, further consents to service of process by nationally recognized overnight courier service
guaranteeing overnight delivery, or by registered or certified mail, return receipt requested, at its address specified pursuant
to Section 6.2, and waives and covenants not to assert or plead any objection which they might otherwise have to such manner
of service of process. Notwithstanding the foregoing in this Section 6.8, a party may commence any action, claim, cause
of action, or suit in a court other than the Chosen Courts solely for the purpose of enforcing an order or judgment issued by the
Chosen Courts. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH OF THE PARTIES WAIVES ANY RIGHT TO TRIAL
BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT WHETHER NOW EXISTING
OR HEREAFTER ARISING. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO
PARTY SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT.
FURTHERMORE, NO PARTY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH
A JURY TRIAL CANNOT BE WAIVED.

 

6.9 
Severability. If any provision of this Subscription Agreement shall be invalid, illegal, or unenforceable, the validity,
legality, or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired
thereby and shall continue in full force and effect.

 

6.10 
No Waiver of Rights, Powers, and Remedies. No failure or delay by a party hereto in exercising any right, power,
or remedy under this Subscription Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of
any such right, power, or remedy of such party. No single or partial exercise of any right, power, or remedy under this Subscription
Agreement by a party hereto, nor any abandonment or discontinuance of steps to enforce any such right, power, or remedy, shall
preclude such party from any other or further exercise thereof or the exercise of any other right, power, or remedy hereunder.
The election of any remedy by a party hereto shall not constitute a waiver of the right of such party to pursue other available
remedies. No notice to or demand on a party not expressly required under this Subscription Agreement shall entitle the party receiving
such notice or demand to any other or further notice or demand in similar or other circumstances or constitute a waiver of the
rights of the party giving such notice or demand to any other or further action in any circumstances without such notice or demand.

 

    19

     

    

 

6.11 
Remedies.

 

6.11.1  The
parties agree that the Issuer and the Beneficiaries would suffer irreparable damage if this Subscription Agreement was not
performed or the Closing is not consummated in accordance with its specific terms or was otherwise breached and that money
damages or other legal remedies would not be an adequate remedy for any such damage. It is accordingly agreed that the Issuer
and each of the Beneficiaries shall be entitled to equitable relief, including in the form of an injunction or injunctions,
to prevent breaches or threatened breaches of this Subscription Agreement and to enforce specifically the terms and
provisions of this Subscription Agreement in an appropriate court of competent jurisdiction as set forth in Section
6.8, this being in addition to any other remedy to which any party is entitled at law or in equity, including money
damages. The right to specific enforcement shall include the right of the Issuer and each of the Beneficiaries to cause the
parties hereto to cause the transactions contemplated hereby to be consummated on the terms and subject to the conditions and
limitations set forth in this Subscription Agreement (including, for the avoidance of doubt, the right to directly enforce
each of the covenants and agreements of Subscriber under this Subscription Agreement). The parties hereto further agree (i)
to waive any requirement for the security or posting of any bond in connection with any such equitable remedy, (ii) not to
assert that a remedy of specific enforcement pursuant to this Section 6.11 is unenforceable, invalid, contrary to
applicable law, or inequitable for any reason, and (iii) to waive any defenses in any action for specific performance,
including the defense that a remedy at law would be adequate. In connection with any Action for which any of the
Beneficiaries is being granted an award of money damages, each of the Issuer and Subscriber agrees that such damages, to the
extent payable by such party, shall include, without limitation, damages related to the cash consideration that is or was to
be paid to the Company and any Pre-Closing Holder under the Merger Agreement and/or in connection with this Subscription
Agreement and such damages are not limited to an award of out-of-pocket fees and expenses related to the Merger Agreement
and/or this Subscription Agreement.

 

6.11.2 
The parties acknowledge and agree that this Section 6.11 is an integral part of the transactions contemplated hereby
and without that right, the parties hereto would not have entered into this Subscription Agreement.

 

6.11.3 
In any dispute arising out of or related to this Subscription Agreement, or any other agreement, document, instrument, or
certificate contemplated hereby, or any transactions contemplated hereby or thereby, the applicable adjudicating body shall award
to the prevailing party, if any, the reasonable and documented out-of-pocket costs and attorneys’ fees reasonably incurred
by the prevailing party in connection with the dispute and the enforcement of its rights under this Subscription Agreement or any
other agreement, document, instrument, or certificate contemplated hereby, and, if the adjudicating body determines a party to
be the prevailing party under circumstances where the prevailing party won on some but not all of the claims and counterclaims,
the adjudicating body may award the prevailing party an appropriate percentage of the costs and attorneys’ fees reasonably
incurred by the prevailing party in connection with the adjudication and the enforcement of its rights under this Subscription
Agreement or any other agreement, document, instrument, or certificate contemplated hereby or thereby.

 

6.12 
Survival of Representations and Warranties. All representations and warranties made by the parties hereto in this
Subscription Agreement shall survive the Closing. For the avoidance of doubt, if for any reason the Closing does not occur prior
to the consummation of the Transactions, all representations, warranties, covenants, and agreements of the parties hereunder shall
survive the consummation of the Transactions and remain in full force and effect.

 

6.13 
Headings and Captions. The headings and captions of the various subdivisions of this Subscription Agreement are for
convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions
hereof.

 

    20

     

    

 

6.14 
 Counterparts. This Subscription Agreement may be executed in one or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and
delivered to the other parties, it being understood that the parties need not sign the same counterpart. In the event that any
signature is delivered by facsimile transmission, email, or any other form of electronic delivery, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such signature page were an original thereof.

 

6.15 
Construction. The words “include,” “includes,” and “including”
will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will
be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa,
unless the context otherwise requires. The words “this Subscription Agreement,” “herein,”
“hereof,” “hereby,” “hereunder,” and words of similar import refer to
this Subscription Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend
that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached
any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty,
or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has
not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty,
or covenant. All references in this Subscription Agreement to numbers of shares, per share amounts, and purchase prices shall be
appropriately adjusted to reflect any stock split, stock dividend, stock combination, recapitalization, or the like occurring after
the date hereof.

 

6.16 
Mutual Drafting. This Subscription Agreement is the joint product of the parties hereto and each provision hereof
has been subject to the mutual consultation, negotiation, and agreement of the parties and shall not be construed for or against
any party hereto.

 

7. 
Cleansing Statement; Disclosure.

 

7.1 
The Issuer shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date of this
Subscription Agreement, issue one (1) or more press releases or file with the Commission a Current Report on Form 8-K (collectively
the “Disclosure Document”) disclosing all material terms of the transactions contemplated hereby and by the Other Subscription
Agreements and the Transactions and any other material, nonpublic information that the Issuer, the Company, any of their respective
subsidiaries or any of their respective officers, directors, employees, affiliates or agents has provided to the Subscriber at
any time. prior to the filing of such Disclosure Document. As of immediately following the filing of the Disclosure Document, to
the knowledge of the Issuer, the Subscriber shall not be in possession of any material, non-public information received from the
Issuer, the Company, any of their respective subsidiaries or any of their respective officers, directors, employees, affiliates
or agents that is not disclosed in the Disclosure Document or in prior filings with the Commission. In addition, effective upon
the filing of the Disclosure Document, the Issuer acknowledges and agrees that any and all confidentiality obligations under any
agreement, whether written or oral, between the Issuer or any of its agents, on the one hand, and the Subscriber or any of its
affiliates, on the other hand, shall terminate and be of no further force or effect.

 

7.2  Subscriber
hereby consents to the publication and disclosure in (i) the Form 8-K filed by the Issuer with the Commission in connection
with the execution and delivery of the Merger Agreement, the Proxy Statement, or any other filing with the Commission
pursuant to applicable securities laws, in each case, as and (ii) to the extent required by the federal securities laws or,
exchange rules, the Commission or any other securities authorities, and (ii) any other filings,documents or communications
provided by the Issuer or the Company to any governmental authority or to securityholders of the Issuer, in each case, as and
to the extent required by applicable law or the Commission or any other governmental authority, of Subscriber’s name
and identity and the nature of Subscriber’s commitments, arrangements, and understandings under and relating to this
Subscription Agreement and, if deemed required or appropriate by the Issuer and/or the Company, a copy of this Subscription
Agreement. Subscriber will promptly provide any information reasonably requested by the Issuer and/ or the Company for any
regulatory application or filing made or approval sought in connection with the Transactions (including filings with the
Commission). Notwithstanding anything in this Subscription Agreement to the contrary, the Issuer shall not (and shall cause
the Company not to), without the prior written consent of the Subscriber, publicly disclose the name of the Subscriber or any
of its affiliates or advisers, or include the name of the Subscriber or any of its affiliates or advisers, in any press
release or marketing materials.

 

    21

     

    

 

8. 
Trust Account Waiver. Subscriber acknowledges that the Issuer has established a trust account containing the proceeds
of its initial public offering and from certain private placements (collectively, with interest accrued from time to time thereon,
the “Trust Account”). Subscriber agrees that (i) it has no right, title, interest, or claim of any kind in or
to any monies held in the Trust Account, and (ii) it shall have no right of set-off or any right, title, interest, or claim of
any kind (“Claim”) to, or to any monies in, the Trust Account, in each case in connection with this Subscription
Agreement, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have in connection with
this Subscription Agreement; provided, however, that nothing in this Section 8 shall be deemed to limit Subscriber’s
right, title, interest, or claim to the Trust Account by virtue of such Subscriber’s record or beneficial ownership of securities
of the Issuer acquired by any means other than pursuant to this Subscription Agreement, including any redemption right with respect
to any such securities of the Issuer. In the event Subscriber has any Claim against the Issuer under this Subscription Agreement,
Subscriber shall pursue such Claim solely against the Issuer and its assets outside the Trust Account and not against the property
or any monies in the Trust Account. Subscriber agrees and acknowledges that such waiver is material to this Subscription Agreement
and has been specifically relied upon by the Issuer to induce the Issuer to enter into this Subscription Agreement and Subscriber
further intends and understands such waiver to be valid, binding, and enforceable under applicable law. In the event Subscriber,
in connection with this Subscription Agreement, commences any action or proceeding which seeks, in whole or in part, relief against
the funds held in the Trust Account or distributions therefrom or any of the Issuer’s stockholders, whether in the form of
monetary damages or injunctive relief, Subscriber shall be obligated to pay to the Issuer all of its legal fees and costs in connection
with any such action in the event that the Issuer prevails in such action or proceeding.

 

9. 
Waiver of Sovereign Immunity. With respect to the liability of Subscriber to perform its obligations under this Agreement,
with respect to itself or its property, Subscriber:

 

9.1 
agrees that, for purposes of the doctrine of sovereign immunity, the execution, delivery, and performance by it of this
Agreement constitutes private and commercial acts done for private and commercial purposes;

 

9.2 
agrees that, should any proceedings be brought against it or its assets in any jurisdiction in relation to this Agreement
or any transaction contemplated by this Agreement in accordance with the terms hereof, Subscriber is not entitled to any immunity
on the basis of sovereignty in respect of its obligations under this Agreement, and no immunity from such proceedings (including,
without limitation, immunity from service of process from suit, from the jurisdiction of any court, from an order or injunction
of such court, or the enforcement of same against its assets) shall be claimed by or on behalf of such party or with respect to
its assets;

 

9.3 
waives, in any such proceedings, to the fullest extent permitted by law, any right of immunity which it or any of its assets
now has or may acquire in the future in any jurisdiction;

 

    22

     

    

 

9.4 
 subject to the terms and conditions hereof, consents generally in respect of the enforcement of any judgment or award against
it in any such proceedings to the giving of any relief or the issue of any process in any jurisdiction in connection with such
proceedings (including, without limitation, pre-judgment attachment, post judgment attachment, the making, enforcement, or execution
against or in respect of any assets whatsoever irrespective of their use or intended use of any order or judgment that may be made
or given in connection therewith); and

 

9.5 
specifies that, for the purposes of this provision, “assets” shall be taken as excluding “premises of
the mission” as defined in the Vienna Convention on Diplomatic Relations signed at Vienna, April 18, 1961, “consular
premises” as defined in the Vienna Convention on Consular Relations signed in 1963, and military property or military assets
or property of the Subscriber.]1

 

10. 
Rule 144. From and after such time as the benefits of Rule 144 promulgated under the Securities Act or any other
similar rule or regulation of the Commission that may allow Subscriber to sell securities of the Issuer to the public without registration
are available to holders of the Issuer’s common stock and for so long as the Subscriber holds Shares, the Issuer agrees to
use commercially reasonable efforts to:

 

10.1.1 
make and keep public information available, as those terms are understood and defined in Rule 144;

 

10.1.2 
file with the Commission in a timely manner all reports and other documents required of the Issuer under the Securities
Act and the Exchange Act so long as the Issuer remains subject to such requirements and the filing of such reports and other documents
is required for the applicable provisions of Rule 144; and

 

10.1.3 
furnish to Subscriber, promptly upon Subscriber’s reasonable request, (i) a written statement by the Issuer, if true,
that it has complied with the reporting requirements of Rule 144, the Securities Act, and the Exchange Act, (ii) a copy of the
most recent annual or quarterly report of the Issuer and such other reports and documents so filed by the Issuer, and (iii) such
other information as may be reasonably requested to permit Subscriber to sell such securities pursuant to Rule 144 without registration.

 

If in the opinion of
counsel to the Issuer, it is then permissible to remove the restrictive legend from the Shares pursuant to Rule 144 under the Securities
Act, then at Subscriber’s request, the Issuer will request its transfer agent to remove the legend set forth in Section
2.1.7. In connection therewith, if reasonably required by the Issuer’s transfer agent, the Issuer will, at Subscriber’s
sole expense, reasonably promptly cause an opinion of counsel to be delivered to and maintained with its transfer agent, together
with any other authorizations, certificates, and directions required by the transfer agent from the Issuer or Subscriber that authorize
and direct the transfer agent remove the restrictive legend from such Shares; provided, that, notwithstanding the foregoing,
the Issuer will not be required to deliver any such opinion, authorization, certificate, or direction if it reasonably believes
that removal of the legend could result in or facilitate transfers of securities in violation of applicable law.

 

[Signature Pages Follow]

 

 

 

		1	Note to Draft: To be included for all sovereign
wealth or similar investors.

 

    23

     

    

 

IN WITNESS WHEREOF,
each of the Issuer and Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date set forth below.

 

	 	GOOD WORKS ACQUISITION CORP.
	 	 	 
	 	By: 	                                 
	 	Name: 	 
	 	Title: 	 

 

[Signature Page to Subscription Agreement]

 

     

     

    

 

Accepted and agreed this [●] day
of [●], 2021.

 

	SUBSCRIBER:	 	 	 
	 	 	 	 	 
	Signature of Subscriber:	 	Signature of Joint Subscriber, if applicable:
	 	 	 	 	 
	By:	                                 	 	By:	                  
	Name: 	 	 	Name: 	 
	Title:	 	 	Title:	 
	 	 	 	 	 
	Date: [●], 2021	 	 	 
	 	 	 	 	 
	Name of Subscriber:	 	Name of Joint Subscriber, if applicable:
	 	 	 	 	 
	 	 	 
	(Please print. Please indicate name and capacity of person signing above.)	 	(Please print. Please indicate name and capacity of person signing above.)
	 	 	 	 	 
	 	 	 	 
	Name in which securities are to be registered (if different from the name of Subscriber listed directly above.)	 	 	 
	 	 	 	 	 
	Email Address:	 	 	 
	 	 	 	 	 
	 	 	 	 
	If there are joint investors, please check one:	 	 	 
	 	 	 	 	 
	☐ Joint Tenants with Rights of
    Survivorship	 	 	 
	☐ Tenants-in-Common	 	 	 
	☐ Community Property	 	 	 

 

 

	Subscriber’s EIN: 	 	 	Joint Subscriber’s EIN: 	 
	 	 	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 	 	 
	 	 	 
	 	 	 
	City, State, Zip	 	 	City, State, Zip	 

 

 

	Attn:	              	 	Attn:	                 
	 	 	 	 	 
	Telephone No.: 	 	 	Telephone No.: 	 
	 	 	 	 	 
	Facsimile No.: 	 	 	Facsimile No.:	 
	 	 	 	 	 
	Aggregate Number of Shares subscribed for:	 	 	 
	 	 	 	 	 
	 	 	 	 
	 	 	 	 	 
	Aggregate Purchase Price:	 	 	 

 

	$ 	 	 	 	 

 

You must pay the Purchase
Price by wire transfer of U.S. $ in immediately available funds, to be held in escrow until the Closing, to the account specified
by the Issuer in the Closing Notice.

 

[Signature Page to Subscription Agreement]

 

     

 

 

     

    

 

SCHEDULE I

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

		A.	QUALIFIED INSTITUTIONAL BUYER STATUS

(Please check the applicable subparagraphs):

 

		1.	 ☐ We are a “qualified institutional buyer” (as defined in Rule 144A under
                                                              the Securities Act of 1933, as amended (the “Securities Act”) (a “QIB”)) and have
                                                              marked and initialed the appropriate box on the following pages indicating the provision under which we qualify as a
                                                              QIB.

 

		2.	☐ We are subscribing for the Shares as a fiduciary or agent for one or more investor accounts,
and each owner of such account is a QIB.

 

*** OR ***

 

		B.	ACCREDITED INVESTOR STATUS

(Please check
the applicable subparagraphs):

 

		1.	☐ We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities
Act) or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities
Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as
an “accredited investor.”

 

		2.	☐ We are not a natural person.

 

*** AND ***

 

		C.	AFFILIATE STATUS

(Please check the applicable box)

 

SUBSCRIBER:

 

		☐	is:

 

		☐	is not:

 

an “affiliate”
(as defined in Rule 144 under the Securities Act) of the Issuer or acting on behalf of an affiliate of the Issuer.

 

This page should be completed by Subscriber

and constitutes a part of the Subscription Agreement.

 

     

     

    

 

The Subscriber is a “qualified institutional
buyer” (within the meaning of Rule 144A under the Securities Act) if it is an entity that meets any one of the following
categories at the time of the sale of securities to the Subscriber (Please check the applicable subparagraphs):

 

☐  The
Subscriber is an entity that, acting for its own account or the accounts of other qualified institutional buyers, in the aggregate
owns and invests on a discretionary basis at least $100 million in securities of issuers that are not affiliated with the Subscriber
and:

 

☐  is
an insurance company as defined in section 2(a)(13) of the Securities Act;

 

☐  is
an investment company registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”),
or any business development company as defined in section 2(a)(48) of the Investment Company Act;

 

☐  is
a Small Business Investment Company licensed by the US Small Business Administration under section 301(c) or (d) of the Small Business
Investment Act of 1958, as amended (“Small Business Investment Act”);

 

☐  is
a plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions, for the benefit of its employees;

 

☐  is
an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”);

 

☐  is
a trust fund whose trustee is a bank or trust company and whose participants are exclusively (a) plans established and maintained
by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit
of its employees, of (b) employee benefit plan within the meaning of Title I of the ERISA, except, in each case, trust funds that
include as participants individual retirement accounts or H.R. 10 plans;

 

☐  is
a business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940, as amended (the “Investment
Advisers Act”);

 

☐  is
an organization described in section 501(c)(3) of the Internal Revenue Code of 1986, as amended (the “Internal Revenue
Code”), corporation (other than a bank as defined in section 3(a)(2) of the Act, a savings and loan association or other
institution referenced in section 3(a)(5)(A) of the Act, or a foreign bank or savings and loan association or equivalent institution),
partnership, or Massachusetts or similar business trust; or

 

☐  is
an investment adviser registered under the Investment Advisers Act;

 

☐  The
Subscriber is a dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), acting for its own account or the accounts of other qualified institutional buyers, that in the aggregate owns
and invests on a discretionary basis at least $10 million of securities of issuers that are not affiliated with the Subscriber;

 

☐  The
Subscriber is a dealer registered pursuant to Section 15 of the Exchange Act acting in a riskless principal transaction on behalf
of a qualified institutional buyer;

 

     

     

    

 

☐  The Subscriber is an investment
company registered under the Investment Company Act, acting for its own account or for the accounts of other qualified institutional
buyers, that is part of a family of investment companies2 which own in the aggregate at least $100 million in securities
of issuers, other than issuers that are affiliated with Subscriber or are part of such family of investment companies;

 

☐  The
Subscriber is an entity, all of the equity owners of which are qualified institutional buyers, acting for its own account or the
accounts of other qualified institutional buyers; or

 

☐  The
Subscriber is a bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association or other institution
as defined in section 3(a)(5)(A) of the Securities Act, or any foreign bank or savings and loan association or equivalent institution,
acting for its own account or the accounts of other qualified institutional buyers, that in the aggregate owns and invests on a
discretionary basis at least $100 million in securities of issuers that are not affiliated with the Subscriber and that has an
audited net worth of at least $25 million as demonstrated in its latest annual financial statements, as of a date not more than
16 months preceding the date of sale of securities in the case of a US bank or savings and loan association, and not more than
18 months preceding the date of sale of securities for a foreign bank or savings and loan association or equivalent institution.

 

Rule 501(a) of Regulation D under the Securities
Act, in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below
listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale
of the securities to that person. Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s)
below which apply to Subscriber and under which Subscriber accordingly qualifies as an “accredited investor.”

 

		☐	Any bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association
or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;

 

		☐	Any broker or dealer registered pursuant to section 15 of the Exchange Act;

 

		☐	Any investment adviser registered pursuant to section 203 of the Investment Advisers Act of 1940
or registered pursuant to the laws of a state;

 

		☐	Any investment adviser relying on the exemption from registering with the Commission under section
203(l) or (m) of the Investment Advisers Act of 1940;

 

		☐	Any insurance company as defined in section 2(a)(13) of the Securities Act;

 

		☐	Any investment company registered under the Investment Company Act or a business development company
as defined in section 2(a)(48) of the Investment Company Act;

 

		☐	Any Small Business Investment Company licensed by the U.S. Small Business Administration under
section 301(c) or (d) of the Small Business Investment Act;

 

		☐	Any Rural Business Investment Company as defined in section 384A of the Consolidated Farm and Rural
Development Act;

 

		☐	Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality
of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

		☐	Any employee benefit plan within the meaning of ERISA,
if (i) the investment decision is made by a plan fiduciary, as defined in section 3(21) of ERISA, which is either a bank,
a savings and loan association, an insurance company, or a registered investment adviser, (ii) the employee benefit plan has
total assets in excess of $5,000,000 or, (iii) such plan is a self-directed plan, with investment decisions made solely by
persons that are “accredited investors”;

 

 

 

		2	“Family of investment companies”
means any two or more investment companies registered under the Investment Company Act, except for a unit investment trust whose
assets consist solely of shares of one or more registered investment companies, that have the same investment adviser (or, in
the case of unit investment trusts, the same depositor); provided that, (a) each series of a series company (as defined in Rule
18f-2 under the Investment Company Act) shall be deemed to be a separate investment company and (b) investment companies shall
be deemed to have the same adviser (or depositor) if their advisers (or depositors) are majority-owned subsidiaries of the same
parent, or if one investment company’s adviser (or depositor) is a majority-owned subsidiary of the other investment company’s
adviser (or depositor)

 

     

     

    

 

		☐	Any private business development company as defined in section 202(a)(22) of the Investment Advisers
Act;

 

		☐	Any (i) corporation, limited liability company or partnership, (ii) Massachusetts or
similar business trust, partnership, or limited liability company, or (iii) organization described in section 501(c)(3) of
the Internal Revenue Code of 1986, as amended, not formed for the specific purpose of acquiring the securities offered, and with
total assets in excess of $5,000,000;

 

		☐	Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring
the securities offered, whose purchase is directed by a sophisticated person as described in Section 230.506(b)(2)(ii) of Regulation
D;

 

		☐	Any entity in which all of the equity owners are institutional “accredited investors.”

 

		☐	Any entity, of a type not listed in paragraphs a(1), a(2), a(3), a(7), or (a)(8) of Rule 501(a)
of Regulation D under the Securities Act, not formed for the specific purpose of acquiring the securities offered, owning investments
in excess of $5,000,000; or

 

		☐	Any “family office,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers
Act of 1940: (i) with assets under management in excess of $5,000,000, (ii) that is not formed for the specific purpose of acquiring
the securities offered, and (iii) whose prospective investment is directed by a person who has such knowledge and experience in
financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment.

 

☐ Any
natural person whose individual net worth, or joint net worth with that person’s spouse, exceeds $1 million.

 

☐ Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that
person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income
level in the current year.

 

☐ Any
entity in which all of the equity owners are accredited investors as determined under any of the two immediately preceding sections
above.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}]]